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PREFACE

The phenomena of biological transport are well known but poorly
understood.

Across the plasma membranes of all living cells there is a

continuous exchange of material.

Some substances move passively, others

through the interposition of metabolic processes.

In some cases the per-

meability remains constant in time, but in other important examples the
permeability to certain substances can be radically altered.

Altered per-

meability to certain ions accounts for the excitability of nerve and muscle,
and altered permeability to water is basic to osmoregulation in land vertebrates.

In nerve and muscle, the stimulus producing the alteration in

permeability is either an electric current flow or a neurohumor, such as
acetylcholine.

In the osmoregulatory organs of the land vertebrates, the

stimulus to alteration of water permeability is one of the neurohypophyseal
hormones.
The work to be described herein was undertaken in an attempt to
understand a little better how neurohypophyseal hormones stimulate a change
in the water permeability of certain cells, in particular, the epithelial
cells of the toad bladder.
not uncovered.

The mechanism of the permeability change was

But something was learned of the ways in which these cells

may limit the activity of the neurohypophyseal hormones and, hence, control
the effect of the hormones upon them.
I would like to acknowledge the help and encouragement given me by
my research advisers, Dr. Philip Siekevitz and Dr. Howard Rasmussen.

I

would like to thank Dr. Vincent du Vigneaud, Professor of Biochemistry,
Cornell Medical School, for his generous gift of oxytocin.
to thank Miss Elizabeth Bowman, who typed this thesis.
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ABSTRACT

The urinary bladder of the toad, Bufo marinus, was homogenized and
the particle-free supernatant fraction prepared.

Incubation of this fraction

with the hormones, oxytocin, arginine vasopressin, lysine vasopressin, and
oxytocin ring amide caused their inactivation.

The decrease in hormone ac-

tivity was roughly exponential with the time of incubation.

The hormone

inactivating activity of the supernatant fraction was decreased by treatment with N-ethylmaleimide, by heating to 50
storage at -20

C.

C for 5 minutes, and by cold

The decrease in activity due to cold storage, but not

that due to either of the other two treatments, was reversed by the addition
of 1 mM cysteine shortly before incubation with hormone.

Ammonium sulfate

fractions of the supernatant fraction were prepared and tested for oxytocin
inactivating activity.

The fraction precipitating between 50 and 70%

saturation was the most active.

In the presence of cysteine, it inactivated

35 m|_M oxytocin per mg protein per hour.

In the absence of cysteine, the

same fraction, after being passed through Sephadex G-25, inactivated 16 m|_M
oxytocin per mg protein per hour.
The incubation mixtures of the most active ammonium sulfate fraction
and oxytocin (no cysteine) was examined chromatographically, following TCA
precipitation of the protein.

After an incubation of 4 hours at 30

oxytocin could be detected on a paper chromatogram.

C no

Moreover, there was an

increase in ninhydrin positive material as compared with the controls.

The

same incubation mixture was subjected to performic acid oxidation and then
chromatographed.

A dense spot corresponding to cysteic acid was obtained.

This was interpreted as indicating that the N-terminal half-cystinyl-tyrosine
bond of oxytocin had been split.
The ammonium sulfate fractions were also tested for their splitting
of the synthetic substrate L-cystine-di-/2-naphthylamide (CDNA).

This sub-

strate, like oxytocin, contains a N-terminal cystinyl-peptide bond.

Again

the most active fraction was that precipitating between 50 and 70% saturation.
In the presence of 1 mM cysteine, it liberated 70 m|_M /3-naphthylamine per
mg protein per hour.
tocin.

This was about twice its rate of inactivation of oxy-

This CDNAase activity was increased by cysteine and decreased by N-

ethylmaleimide, iodoacetic acid, and oxidized glutathione.

It was decreased

iv

also by heating to 50

C for a few minutes.

It appeared on the basis of

these results that CDNA and oxytocin were being attacked by the same enzyme.
The ammonium sulfate fractions were tested for their splitting of L-leucine$ -naphthylamide (LNA).

The pattern of the fractionation of the LNAase

activity was the same as that of the CDNAase activity.

By a number of

criteria, it appeared that LNA and CDNA were being split by the same enzyme.
On the basis of these results it was concluded that a hormone inactivating
enzyme is present in the toad bladder which splits N-terminal cystinylpeptide bonds and also N-terminal leucinyl-peptide bonds.

It was compared

with pregnancy serum oxytocinase and leucine aminopeptidase and was found
to be different than either of these.
The inactivation of oxytocin by the intact toad bladder was then
tested.

It was found that the effect of a dose of oxytocin on the water

permeability of the bladder decreased with time, but that this decrease was
not due simply to inactivation of the hormone.
its serosal bath

The bladder released into

an inhibitor of the action of hormone, and it was inferred

that this inhibitor was released in response to the hormone.

A theoretical

model of hormone action was constructed in which the hormone is inactivated
in the epithelial cells of the bladder, and the product of this inactivation
acts as a competitive inhibitor of the hormone in its attachment to a receptor site.

The solution of the mathematical expressions of this model

fit the experimental data of the time course of the action of the hormone,
over the entire concentration range.

In fitting the theoretical solution

to the experimental data, six constants were obtained, four of which are
probably characteristic of the hormone species.

The implications of this

kind of kinetic analysis for the understanding of hormone-structure-function
relationships were discussed.

It was suggested that a possible physiological

role for the inactivating enzyme, found in the first part of this work, is
to convert the hormone to an inactive product which acts as an inhibitor of
hormone action.

In this way, the action of hormone upon a cell could be

controlled by the cell itself.
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INTRODUCTION

This thesis is a study of the interaction of neurohypophyseal hormones with the bladder of the toad, Bufo marinus.

Two broad fields are

involved here, hormone function and biological transport.

In the controlled

transport of water in certain vertebrate osmoregulatory organs and in the
function of neurohypophyseal hormones, these two fields become demonstrably
one.

We shall begin our discussion with a short history of the function of

the neurohypophysis and of its hormones.
A. History of the Neurohypophyseal Hormones
Only the highlights of the advance will be given.

Dale (1957) has

presented a more complete account of this story and of the confusion and
artifacts that plagued early workers in this field.

Before 1895 virtually

nothing was known of the function of the pituitary gland, or hypophysis.
1895.
extracts.

Oliver and Schafer discovered the pressor effect of pituitary

They injected extract of whole pituitary intravenously into dogs

and observed a rise in blood pressure caused by a pronounced vasoconstriction.
1898.

Howell prepared extracts of various parts of the pituitary

and found that the pressor substance was limited to the neural lobe.
1906.

Dale discovered the oxytocic effect.

He found that extracts

of the pituitary caused contraction of the pregnant cat uterus in situ.
1909.

Dale investigated the pressor substance.

He found that it was

excreted in the urine, that it was stable to pepsin and to boiling in dilute
acid, but that it was readily destroyed by trypsin and hot alkali.
1910.

Ott and Scott discovered the milk-ejecting effect of pituitary

extracts.
1912.

Paton and Watson discovered the blood pressure depressing ef-

fect of injected pituitary extracts in birds (opposite to the effect in
mammals.
1913.

Von der Velden and Faruci, separately, discovered the anti-

diuretic effect of pituitary extract in a successful application to the
treatment of diabetes insipidus, a disease characterized by the excretion
of a highly dilute and copious urine.
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1919.

Dudley achieved a partial separation of the oxytocic and the

pressor activities, suggesting that at least two separate substances might
be responsible for the effects of the extracts.
1925.

Starling and Verney perfused an isolated kidney with a heart-

lung preparation.
betes insipidus.

The kidney produced a dilute, copious urine, as in diaA much smaller volume of concentrated urine was produced

instead if either pituitary extract was added to the perfusing blood or an
isolated head was added to the preparation and the perfusate passed through
it as well as through the kidney.

This was good evidence for the physio-

logical function of the antidiuretic substance in pituitary extract.
1928.

Kamm and Grote achieved a good separation of oxytocin and

vasopressin.
1953.

Du Vigneaud and his co-workers and Tuppy, separately, deter-

mined the structure of oxytocin.

Du Vigneaud and co-workers synthesized

oxytocin, and, in the following years, synthesized the other naturally occuring hormones, arginine vasopressin, lysine vasopressin, and arginine vasotocin (Table I) as well as many interesting analogs of these.
B. Natural Distribution of the Neurohypophyseal Hormones
Oxytocin, or some peptide closely resembling oxytocin, is found in
all vertebrates examined except in the cyclostomes (Table I). In addition,
all non-mammalian vertebrates, except the elasmobranchs, elaborate arginine
vasotocin.
Among the mammals, the neurohypophysis of the hog and of the hippopotamus contain lysine vasopressin, and that of all the other mammals examined
contains arginine vasopressin.
Later we will discuss the physiological functions of these hormones.
First let us say a few words about the neurohypophysis itself.
C. Structure and Function of the Neurohypophysis
The principal point we want to make in this section is that the neurohypophyseal hormones are produced in the nerve cells of certain hypothalamic
nuclei and are transported down the axons of these cells to their termination
in the neurohypophysis where the hormones are stored until released into the
circulation (Green and Maxwell, 1959).

TABLE I
The Naturally Occurring Neurohypophyseal Hormones
1234 5 6789
CyS-Tyr'Ileu-Glu(NH2).Asp(NH2)•CyS-Pro-Leu-Gly(NH2)

OXYTOCIN

Analog

Other name

Oxytocin

Where found

References

All vertebrates
except cyclostomes.

Heller and
Pickering
(1961)

Arg8.- oxytocin

arginine vasotocin

Cyclostomes,
fresh water and
marine teleosts,
reptiles, and
birds.

Phe^, Arg8-oxytocin

arginine vasopressin

Man, ox, horse,
sheep, rat, dog,
monkey, camel,
oppossum, spiny
anteater.

3
8
Phe , Lys -oxytocin

lysine vasopressin

Hog and hippopotamus.

Dicker (1961)
and Sawyer
(1961).
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In Figure 1 (from Fulton, 1955) we can see the neural connections
in the hypophysis of the cat.

Note also the vascular connections, especially

those between the posterior lobe and the anterior lobe.

Table II contains

a system of nomenclature for the mammalian hypophysis (Bard, 1956).

TABLE II
Nomenclature of the Mammalian Hypophysis

Adenohypophysis (Lobus glandularis)

Lobus nervosus
Neurohypophysis

1. Pars distalis (Anterior lobe)
2. Pars tuberalis
3. Pars intermedia
(Posterior
lobe)
1. Infundibular process

4

Infundibulum

1. Infundibular stem
2. Median eminence

A hypophysis is highly characteristic of the vertebrates (Green and
Maxwell, 1959).

It is not, as such, found among the other chordates.

On

the other hand, all invertebrates above the coelenterates have neurosecretory
cells, and structures functionally analogous to the neurosecretory nuclei of
the hypothalamus, to the neurohypophysis, and to the adenohypophysis are found
in crustaceans and insects (Hanstrom, 1957).
It is also characteristic of vertebrates that the blood supply to the
adenohypophysis first comes in contact with the neurohypophysis (Green and
Maxwell, 1959).

In the cyclostomes and fish the neurohypophysis is relatively

simple, being little more than a thickening of the floor of the diencephalon.
The blood supply to the adenohypophysis first passes adjacent to the neurohypophysis.

It is thought that in these classes the neurohypophysis functions

principally as a link in the central nervous system control over the adenohypophysis (Sawyer, 1961).

The neural lobe, as a distinct division of neuro-

hypophysis, appears first in certain lungfish and amphibians.

It develops

from the caudal portion of the primitive neurohypophysis and is distinguished
from the median eminence by its characteristic blood supply.

While effluent

blood from the median eminence enters the hypophyseal portal vessels, the
blood leaving the neural lobe enters the systemic circulation.

Hence with the

SUP. HYP. A

CAV. SIN.

=7^ AW.&

POST. LOBE.

ANT. LOBE
PORT. VEN

Figure 1.

CAV. SIN.

The principal neural and vascular connections of the

hypophysis of the cat, in schematic longitudinal section. (From
Fulton, 1955)
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invasion of land, the primitive neurohypophysis differentiated and the neural
lobe secreted into the general circulation substances intimately concerned,
as we shall see, with osmoregulation.
In the next section we shall discuss briefly the storage of the hormones and their release from the neurohypophysis.

After that we shall dis-

cuss the effects of the hormones on their target organs.
D. Storage and Release of the Neurohypophyseal Hormones
The ratios of vasopressor to oxytocic activities, assumed to equal
approximately the ratios of oxytocin to vasopressin, are generally different
in the hypothalamus and the neurohypophysis.

For instance, in the dog's

hypothalamus, V/0 = 17, and in its neurohypophysis, V/0 = 1.5 (Van Dyke, 1957).
For many species (man, cat, rat, dog, sheep, pig, and horse), V/0 of the
neurohypophysis is approximately one (Acher and Fromageot, 1957).
this ratio may be quite different in the immature animal.
rat, V/0 = 12, while at 40 days, V/0 = 1.

However

At birth, in the

These studies suggest independent

synthesis of oxytocin and of vasopressin in mammals.

Moreover, granules

centrifuged from homogenates of the neural lobe contain 90% of the hormone
activity, and a separation of these granules into a fraction with high pressor
activity and one with high oxytocic activity has been reported (La Bella et al.,
1962).
There is, incidentally, a great excess of stored hormone compared to
the amounts needed to elicit a physiological response.

For example, 1 mg of

j

beef posterior pituitary powder contains 1 unit of oxytocic activity and 1
unit of pressor activity, while doses eliciting definite physiological effects
are of the order of magnitude of a few milliunits and often less.
Release of hormones from the neurohypophysis can be elicited in many
ways.

Intracarotid and intravenous injections of hypertonic saline solution,

injection of hypertonic saline directly into the hypothalamus, electrical
stimulation of the neurohypophysis or of the nucleus supraopticus, injection
of acetylcholine into the nucleus supraopticus, hemorrhage or other acute
reductions in extra-cellular volume, dehydration, suckling, and coitus are
stimuli which release hormone (Dicker, 1961; Share, 1961).
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Whatever the stimulus, oxytocin and vasopressin are released together,
and, judging from the resultant physiological effects, twenty to one hundred
times as much oxytocin as vasopressin is released per stimulus (Dicker, 1961).
E. Antidiuretic and Related Effects of the Neurohypophyseal Hormones
It has already been mentioned that the development of a separate
neural lobe, releasing its contents into the systemic circulation, is coincident with terrestrialism.

We shall see in this section that the hormones

of the neural lobe stimulate water-conservation.

Now marine fish conserve

water through more or less permanent structural modifications of their kidney
such that their urine flow is quite low, and through the excretion of excess
salts and of nitrogenous wastes by their gills.

Fresh-water fish, on the

other hand, put out a voluminous, dilute urine, and reabsorb some salt in
kidneys and some salt from the environment through the gills.

For these

aquatic vertebrates, the environment and its stresses are relatively constant.
If the environment does change, as it does for the eels and salmon, the first
of which breeds at sea and matures in fresh water, the second of which breeds
in fresh water and matures at sea, the changes are gradual and long-lasting.
But for the typical land vertebrate, one moment scorched by the sun, the
next moment deluged by rain, some mechanism seems necessary to permit rapid
osmoregulation.

Such a mechanism is the complex of osmoreceptors in the

brain, plus hormonal transmitters, plus effector organ or organs, all of which
are present in the tetrapods.

What these organs are specifically, and how

they work, we will discuss next.

There are, of course, other important mecha-

nisms of osmoregulation, and we will try to mention some of these as well.
An interesting and charming account of the evolution of vertebrate osmoregulation is presented by Homer Smith (1959).
1)

Vertebrate osmoregulation:

Little is known about the mechanism

of water and salt balance of the most primitive living vertebrates, the cyclostomes (Krogh, 1939).

The tissues and body fluids of the marine forms are

in osmotic equilibrium with the environment.

One species, Petromyzon marinus,

matures in the sea but migrates to fresh water to breed.

Two other species

live in fresh water but can penetrate into brackish water.

The urine is pro-

duced by ultra-filtration, and there is probably some excretion and reabsorption in a short convoluted tubule.
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The elasmobranchs maintain themselves by the unique trick of retaining urea.

The blood of the marine species is hypertonic to sea water.

The electrolyte concentration of their blood, however, is about the same as
that of fresh water teleosts.

The difference is made up by urea, the con-

centration of which may reach 2.0 - 2.5%.

The urea concentration in the blood

of most vertebrates is about 0.01 - 0.03%.
hypotonic to their blood.

The urine of elasmobranchs is

They actually have excess water due to their high

internal concentration of urea.

They also possess an anal salt gland which

secretes a solution isotonic to blood with twice the NaCl concentration and
one-twentieth the urea concentration.

The fresh water sawfish, Prlstes

microdin, excretes a very dilute urine and retains far less urea than sea
water forms (Smith, 1936).
Fresh water teleosts excrete a copious, dilute urine.
tubules reabsorb salt from the ultra-filtrate.

Salt is absorbed by the gills;

e.g., the goldfish will reduce the concentration of Cl
(Prosser, 1952).

The kidney

from 1 mM to 0.02 mM

Water enters chiefly through the gills and oral membranes.

Fresh water fish do not drink, and their integument is impermeable to water.
Marine fish drink sea water, absorb both salt and water from the in++
++
=
+
+
testine, and excrete Mg , Ca , and SO. in the urine, and excess Na , K ,
and Cl through the gills (Prosser, 1950). Urine output is much reduced, and
commonly the nephron degenerates, with a shortening of the tubules and even
a disappearance of the glomeruli as in the toad fish, Opsanus tau.

In this

species the urine flow is 2.5 ml per kg per day as compared to 200-400 ml per
kg per day in the fresh water gar-pike.
cretes excess salt through its gills.

In sea water the eel drinks and exIn fresh water it excretes a dilute

urine and replaces salt by feeding.
The African lung-fish, Protopterus aethiopicus, is an interesting water
conserver (Smith, 1959).
mucous.

In summer it burrows and secretes a hardening

It aestivates in brick-hard mud and can remain viable for years.
The importance of neurohypophyseal hormones in water balance in fish

is uncertain, even though a plentiful amount of arginine vasotocin is present
(Sawyer, 1961).

Neither mammalian nor teleostean posterior lobe preparatives

appear to influence water retention either in marine or in fresh water fish
(Pickford, 1959).
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"When the Amphibia abandoned the scales of their piscine ancestors
in favor of a naked skin they encountered a double hazard, excessive
hydration of the body when they were immersed in water and excessive
dehydration when they left it" (Smith, 1959).

The plasma of a frog (Conway,

1945) or of a toad (Leaf et al., 1958) is isotonic to about 120 mM NaCl.
The skin is permeable to water (von Hevesy et al., 1935).

In fresh water,

then, considerable water flows in and must be eliminated.

Again, as in fresh

water teleosts, balance is achieved by excretion of a large volume of highly
dilute urine (Krogh, 1939).

Dilution of the urine occurs in the distal con-

voluted tubule (Walker et al., 1937).
In air, amphibians lose water rapidly.

There is, in this respect,

little difference in the rate of loss of water from equally large individuals
of fully aquatic species (e.g., Rana clamitans) and almost fully terrestrial
species (e.g., Bufo boreas) (Thorson, 1955).
water by absorbtion through the skin.
been observed to do so (Thorson, 1955).

Frogs and toads regain lost

Tadpoles drink but adults have not
Dehydration and injections of neuro-

hypophyseal hormones increase the rate of uptake of water through the skin
(Ewer, 1952).
Many species respond to dehydration or neurohypophyseal hormones by
an antidiuresis.

Dehydrated Rana pipiens and Bufo bufo almost cease to form

urine (Chew, 1961), and dehydration or injection of neurohypophyseal hormones
produce an antidiuresis in Bufo marinus (Sawyer, 1957) (Figure 2).

Sawyer

found that at moderate doses there was a pronounced decrease in urine flow
with no change in glomerular filtration rate (Figure 2). At higher doses the
filtration rate was decreased somewhat, but he concluded that tubular reabsorbtion of water accounted almost entirely for the antidiuresis.

No am-

phibian, of course, can produce a urine more concentrated than its plasma,
and as a rule the urine is hypotonic to plasma.
Charles Darwin considered it "well ascertained, that the bladder of
the frog acts as a reservoir for the moisture necessary to its existence...".
Injections of Pitressin and Pitocin stimulate the transfer of water from the
bladder to the lymph in Bufo carens and Bufo regularis (Ewer, 1952).

We will

have more to say on the subjects of the bladder and the skin when we discuss
their in vitro preparations.
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The reptiles are well adapted to land (Prosser, 1950).
either are viviparous or lay cleidoic eggs.
water.

They all

Their skin is impermeable to

Though, at best, their urine is only isotonic with their plasma,

very small quantities are excreted.

For example, the lizard, Trachysaurus

rugosus, when hydrated forms 0.57 ml per 100 gm per hr and when dehydrated,
0.024 ml per 100 gm per hr, which is only 5% of the rate for a dehydrated
rat (Chew, 1961).

Two factors contribute to the low urine flow, a low fil-

tration rate and the excretion of uric acid.

The renal corpuscles of most

land reptiles are poorly developed to begin with, and neurohypophyseal hormones can reduce filtration

rates even more.

These hormones cause an anti-

diuresis in T, rugosus, for instance, similar to that observed in dehydration.
Moreover, there is osmotic reabsorption of water from the more or less hypotonic urine in the cloaca.

As water is withdrawn, uric acid precipitates,

freeing more water for reabsorption.

The principal avenue of water loss in

the land reptiles is evaporation from the lungs.

This is diminished by

behavioral adjustments such as burrowing and quiescence.
plenished in most reptiles by drinking.
drinking of the giant Galapagos tortoise.
water in its bladder for several days).

Water is re-

(Darwin describes the gargantuan
This beast seems to store fresh
In some species, excess salt is

eliminated by nasal secretion of a concentrated saline solution; this occurs
in a brackish water terrapin, Malacolemys terrapin, and in the loggerhead
turtle, Caretta caretta.

The same function is ascribed to the nasal gland

of sea snakes and of sea crocodiles (Schmidt-Nielsen and Fange, 1958).
Birds can produce urine hypertonic to their plasma.

This ability is

associated with the appearance of a thin segment, the loop of Henle, in the
bird nephron.

The maximum concentration of urine of the house finch, cor-

morant, and chicken is about twice the concentration of their plasma (Chew,
1961) . Neurohypophyseal hormones or dehydration cause an increase in concentration of the urine, and also a decrease in the filtration rate down to
10% of the normal rate.
cularized.
high.

As in reptiles, the renal corpuscles are poorly vas-

Birds, also, are uricotelic.

Evaporative loss from birds is

They replenish their water by drinking.

In response to salt loading,

such as the ingestion of sea water, marine birds secrete a concentrated salt
solution from their nasal gland; e.g., 900-1,000 mEq. Na + per 1. is the
maximum concentration of the nasal secretion of Leach's Petrel (SchmidtNielsen, 1960).
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In mammals, the kidney can produce highly concentrated urine.

The

maximum ratios of urine concentration to plasma concentration for a few
species are (Smith, 1959): man, 4.2; dog, 4.5; seal, 5.6; kangaroo rat, 17.
A diagrammatic representation of the mammalian nephron is shown in Figure 3.
The renal corpuscle and the tubules are in the cortex of the kidney, and the
loops of Henle extend into the medulla, parallel to the collecting ducts.
The concentrating ability of the mammalian kidney is directly related to the
thickness of the renal medulla (Schmidt-Nielsen and O'Dell, 1961).

The

thickness of the medulla is an indication of the length of the loops of Henle.
Micropuncture and direct cryoscopic examination have indicated that in the
concentrating kidney there is a progressive increase in electrolyte and urea
concentrations from the cortex to the medullary papilla, and moreover, that
the concentrations in the collecting ducts, in the loops of Henle, and in
the blood vessels are equal at each level (Wirz, 1957; Wirz, 1961).

The

mechanism, now accepted, explaining these observations is as follows: First,
about 85% of the glomerular filtrate is isotonically reabsorbed in the proximal tubules.

The urine then passes through the loops of Henle.

In this

-t-

process Na is actively reabsorbed from the contents of the lumen along the
ascending limb of the loop, which is impermeable to water. The descending
limb, through which the urine passed first, is permeable to water, or to
water and salt.

In either case, the concentration of the urine increases

by passive diffusion of water out, or water out and salt in, as it flows down
the descending limb into the progressively more concentrated regions of the
medulla.

As the urine turns the corner at the tip of the loop and begins

to ascend, a progressive dilution occurs due to the active reabsorbtion of
salt into the extra-lumenal fluids.

This arrangement is formally analogous

to the counter-current multiplication system proposed by Wirz, Hargitay, and
Kuhn (1953), and, according to their analysis, would account for the observed
concentration profile,

When the urine reaches the distal convoluted tubule,

in the cortex, it is hypotonic.

In the concentrating kidney, the distal

tubule is permeable to water and reabsorbtion occurs to isotonicity.
the urine flows down again through the collecting ducts.
the final concentrating occurs.

Now,

It is here that

In the concentrating kidney, the collecting

duct epithelium is permeable to water, and the urine comes into osmotic
equilibrium with the progressively more concentrated fluids in passing from
the cortex through the medulla.

The antidiuretic effect of the neurohypo-

renal
artery

efferent
arteriole

renal vein

renal pelvis
Figure 3.

Diagrammatic representation of the mammalian nephron

(From Smith, 1959)
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physeal hormones (Figure 4) is explained in terms of this mechanism as increasing the water permeability of the collecting ducts, of the distal convoluted tubules, and, possibly (Wirz, 1961) of the descending limb of the
loop of Henle (Figure 5 ) , Antidiuresis is achieved without significant
change in the glomerular filtration rate.

In diuresis, in the absence of

antidiuretic hormones, water is not reabsorbed from the urine in the distal
tubule, and urine entering the collecting ducts is hypotonic, and of greater
volume than during antidiuresis.

In passing through the collecting ducts

there is now no change in concentration or in volume, and a dilute, voluminous
urine results.

The energy requiring step in the concentration of urine is

the transport of salt, both in the proximal tubules, in order to reduce the
volume entering the loops, and in the loops themselves, in order to produce
the necessary concentration profile.

Mechanical energy, supplied by the heart,

is also necessary, for if the flow is stopped, the mechanism fails (Wirz, 1961).
The action of the antidiuretic hormones, then, is to permit passive flow of
water down pre-existing concentration gradients.

We shall see that these

hormones have a similar function in the amphibian skin and bladder.

The

efficiency of the concentrating mechanism of the mammalian kidney is such
that it, together with certain behavioral adjustments, permits certain species
to remain in balance on metabolic water solely.

The kangaroo rat, Dipodomys

merriami, can live without water on air-dried seeds containing 5-10% free
water (Chew, 1961).
2) Amphibian skin and bladder ; The effects of neurohypophyseal hormones on the isolated skin and bladder have been reviewed by Leaf and Hays
(1961).

These hormones increase the permeability to water of the skin and

of the bladder
membranes.

when added to the solution bathing the serosal side of these

Water moves passively across these tissues in the direction of

its concentration gradient, at a rate linearly proportional to this gradient.
The bag-shaped bladder can be simply tied to the end of a glass tube, dilute
Ringer's placed inside (the mucosal side) and the tube and bladder suspended
in Ringer's, in contact with the serosal side, to which hormone can be added.
The water loss can be determined by periodic weighings of the tube and attached bladder.

The effects of hormones on such preparations of the toad

and frog bladder are shown in Figure 6.

X X
A.
Urine flow
c
E 3

35
30

1,25
z:
=* 20
15
10
5

3
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Figure 4.

00

60
80
Time, min.

120

The effect of oxytocin and vasopressin on urine flow, Na, and

K excretion during water diuresis in the dog.
The animal was given 300 ml water by mouth at zero time.

The

open circles represent the results of the intravenous injection of 60 mU
oxytocin at X.

The filled circles represent the results of the intra-

venous injection of 4 mU vasopressin at Y.
1957)

(From Brooks and Pickford,

T

sodium
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Figure 5.

The possible sites of action of the antidiuretic hormone

(ADH) in the nephron and the collecting duct.

(From Wirz, 1957)
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_HOURS

The effect of the neurohypophyseal hormones on the water

permeability of the amphibian bladder.
A. The effect of AVP, 0.0125 ug per ml, upon the weight loss
of the toad bladder, in ordinary Ringer's and in Ringer's containing
choline in place of sodium.

The serosal solution and the hormone

were renewed at the arrows.

The time is in minutes.

et al., 1960).

(From Rasmussen

B. The effects of oxytocin and arginine vasotocin on

a single bullfrog bladder.

(From Sawyer, 1960).
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Now it was early observed that the movement of deuterium-labelled
water across the skin or bladder, in the absence of an osmotic gradient,
could not account for the net flux of water observed in osmotic flow.

In

fact, in the absence of hormone, such diffusion flow could account for only
one-sixth of the net flux, and, in the presence of hormone, for less than
1% of the net flux.

One way of explaining these observations is to assume

that water moves through the permeability barriers of the skin and of the
bladder in pores, through which an osmotic pressure gradient acts as an
equivalent hydrostatic pressure gradient in producing a bulk flow of fluid.
Hormone, it is proposed, acts to increase the average radius, r, of these
pores.

Assuming laminar flow through these pores, the bulk flow increases
4
2
with r , while the diffusion flow only with r . According to Leaf's calo
culations, the average pore radius before hormone is 8 A and after hormone,
o
40 A, a figure larger than one would think practical. Qualitatively, nonetheless , the aqueous channel theory gains support from the observed permeability and flux of small, uncharged, water-soluble molecules, in the
presence and absence of hormone and of bulk flow. One modification which
has been proposed is that a thin diffusion barrier may be in series with
the hormone-effected, porous barrier.

If this diffusion barrier were thin

enough, and permeable enough to water, the flow of water would have the
same character as that through pores while the movements of other molecules,
such as thiourea, would be retarded.
In the toad bladder, the permeability barrier effected by the neurohypophyseal hormones is probably at the mucosal surface of the epithelial
cells.

The epithelium, covering the mucosal surface of the bladder of the

toad, Bufo marinus, is 3 to 10 microns thick and consists of squamous epithelial cells, goblet cells, and a third class of cells containing many
mitochondria.

This epithelium is supported on a lamina propria 30 to several

hundred microns thick and containing collagen fibrils, bundles of smooth
muscle fibers, and blood vessels (Figure 7 and 8; Peachey and Rasmussen,
1961).

The epithelial cells, which greatly outnumber the other types of cells

in the epithelium, are tightly held together by a terminal bar apparatus, and
are closely apposed near the bladder lumen as well.

Phase micrographs (Figure

9) of the bladder, fixed during hormone-induced, osmotic flow of water, with
dilute Ringer's on the mucosal side, show swelling of the epithelial cells
as compared to the controls without hormone, making it very probable that

Figure 7.

Low magnification light micrograph of a paraffin section of

the toad's urinary bladder stained with iron alum-iron hematoxylin and
counterstained with eosin.

The epithelium (ec) covers the lamina propria

(lp) on its mucosal surface.

Within the lamina propria are blood vessels

(bv) and smooth muscle fibers (sm). An incomplete mesothelium (ms) is
found on the serosal side of the bladder wall.
X 75.

(From Peachey and Rasmussen, 1961).

Spencer 32 mm objective.

Figure 8.

Survey electron micrograph of a normal bladder epithelium

illustrating three types of cells found in this cell layer.

Three

squamous epithelial cells (ec) form the surface bounding the bladder
lumen (bl) in this figure.
cells into the lumen.

Microprojections (mp) extend from these

Also indicated are a goblet cell (gc) con-

taining large, dense droplets and vesicles with either clear (cv) or
dense (dv) contents.
are also seen.

Three cells containing numerous mitochondria

Within each of these latter cells, the mitochondria

are of uniform size, but there is considerable variation in size from
one cell to another.
cell mc

The largest mitochondria are found in cell mc ;

has mitochondria of an intermediate size, and cell mc

the smallest mitochondria in this field.
Peachey and Rasmussen, 1961)

EMU-2B. X 14,000.

has

(From

Figure 9.

Phase micrographs of bladders fixed prior to addition of

hormone (a), during hormone-induced water flow (b), and after removal
of the hormone (c).
In all cases, the bladder had dilute Ringer's on the mucosal
side and Ringer's on the serosal side.

The epithelial cells (ec)

fixed in the presence of hormone appear swollen (b). Zeiss X 90 phase
objective. X 900.

(From Peachey and Rasmussen, 1960)
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the passage of water is actually through these cells.

Dilute Ringer's

placed on the serosal side of the bladder, even in the absence of hormone,
causes similar swelling of the epithelial cells.

The conclusion drawn from

these observations is that the serosal surface of the epithelial cells is
normally freely permeable to water, while the mucosal surface is relatively
impermeable and becomes permeable only in the presence of hormone (added to
the serosal side.').

Leaf reports similar anatomical evidence from his

laboratory (Leaf and Hays, 1961).

Actually the first indication of the

mucosal barrier was the observation by Leaf that, during anaerobic metabolism, considerably more lactate accumulated on the serosal side of the
bladder than on the mucosal side.

When the permeability of the two surfaces

to lactate was measured, the serosal surface was found to be fifteen times
more permeable than the mucosal surface. Similarly, the labelling of tissue
14
water with T O or C -urea, from the mucosal side, was significantly greater
_
in the presence of hormone than in its absence, as would be expected were
the hormone to act on the mucosal surface of the epithelium, the serosal surface being more or less unchanged. Lastly, measurements of the inulin space
of the bladder with dilute Ringer's on the mucosal side, in the presence and
absence of hormone, showed a nearly 50% increase in cell volume, that is, of
the non-inulin space, in the presence of hormone.

This evidence, of course,

supplements the microscopic observations of swelling of the epithelial cells
during osmotic passage of water, and is further proof that the water passes
through the epithelial cells, not between them, and that the hormone affects
a barrier at or near the mucosal surface of these cells.
The toad bladder, as well as the skin, develops a spontaneous potential difference between mucosal and serosal surfaces of the order of 50 millivolts, with the serosal side positive to the mucosal side.
Na

A net flux of

from mucosal to serosal side, counter to its external electrochemical

gradient, is observed to take place.

An external potential difference can

be impressed upon the toad bladder, just cancelling its spontaneous potential
difference.

In this state, with the potential difference between two points,

close to either surface, equal to zero, the current across the bladder is
called the "short-circuit current" (Ussing and Zerahn, 1951).
is carried entirely by Na , the net flux of Na

This current

being equal to the current

flow, and is, therefore, a good measure of the active transport of Na .
Hormone, added to the serosal surface of the bladder, enhances the short-
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circuit current by a factor of 1.5 to 2 (Figure 10).
increases water permeability 25-50 times).

(Hormone incidentally

At the same time, neurohypo-

physeal hormone significantly increases oxygen consumption and lactate formation, and decreases glycogen content; but these effects of hormone are
abolished in sodium-free Ringer's solution, whereas the metabolism, in the
absence of hormone, is only slightly less in the absence of Na

compared to

that in the presence of Na . In other words, neurohypophyseal hormone, in
4.
the presence of Na , increases the metabolism above the level obtained both
.4.
in the presence and the absence of Na . It certainly seems likely that
this extra metabolism is coupled with the increased Na transport.
On the other hand, the increase in net water flux, in the presence
both of an os_motic gradient and of hormone, does occur in the complete ab4-f
sence of Na and under other conditions during which Na transport does not
occur (Figure 6 ) . The absence of Na transport, of course, means the absence of a stimulatory effect of hormone on oxygen consumption.

Rasmussen

and co-workers (1960) found that arginine vasopressin increased the pero
meability of the bladder kept at 2.5 C, under nitrogen, in choline Ringer's,
_3
_
and in the presence of 10
M CN . In a separate experiment it was found
—2
that 10
M fluoroacetate, an agent known to inhibit glycolysis, did not
inhibit the effect of hormone on the water flux, in choline Ringer's.
There was a slight effect in Na Ringer's. On the basis of this evidence
it is likely that the increase and maintenance of the water permeability,
in the presence of hormone, is not, to any large extent, an energyrequiring process.
Evidence for a site of attachment of the neurohypophyseal hormones,
and possible characterization of this site, have been the objects of further
experiments with the toad bladder.
Bladders were treated with tritium-labelled arginine vasopressin.
These showed a full physiological response.

At the peak of the response to

hormone, the bladders were rinsed and fixed in ethanol.

One set was incu-

bated with 0.1 M glycine in 0.15 M NaHCO , another in 0.1 M cysteine in 0.15
M NaHCO . The residual activity of the bladders of each set was determined.
o
The set washed with cysteine had considerably less residual radioactivity
(Schwartz et al., 1960). If the same experiment were performed on bladders
-3
previously exposed to 10
M N-ethylmaleimide (NEM), known to prevent the
effect of arginine vasopressin on the bladder (Rasmussen et al., 1960), no
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Figure 10.
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The effect of Pitressin on the short-circuit current across

a toad bladder.
Addition of hormone to the mucosal side had no effect. (From
Leaf et al., 1958)
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significant difference between the residual activities of glycine washed
and of cysteine washed bladders was observed.

Similar findings were ob-

tained with pre-treatment of the bladders with methylmercuribromide and
parachloromercuribenzoate, also known to inhibit the response to arginine
vasopressin.
Also, Rasmussen and his co-workers (1960) found that N-ethylmaleimide
added before arginine vasopressin inhibited the increase in permeability,
but that N-ethylmaleimide added after arginine vasopressin inhibited the
decrease in permeability usually observed on the removal of AVP.

Altogether,

this evidence suggested to these workers that the neurohypophyseal hormones
are fixed to their site of action in the bladder by a reversible sulfhydryldisulfide interchange reaction.

Such a mechanism has also been suggested

for the attachment of these hormones in the kidney (Fong et al., 1959), and
for insulin in muscle (Fong et al., 1962).

Insulin, it should be noted, con-

tains, as do the neurohypophyseal hormones, a twenty-membered disulfide ring.
The responses of the bladder to neurohypophyseal hormones are specific.
Neither insulin, glucagon, parathormone, epinephrine, nor angiotensin elicit
them (Leaf and Hays, 1961).

The observation that the excretion of hyaluro-

nidase in the urine increases during antidiuresis (Ginetzinsky, 1958) led to
the suggestion that this enzyme might act on a mucopolysaccharide component
of the water permeability barrier in the collecting ducts, and thereby increase water reabsorbtion and cause an antidiuresis.

However, hyaluronidase

had no effect on the permeability of the toad bladder.

On the other hand,

Rasmussen and his co-workers found that when the mucosal surface of the toad
_3
bladder was briefly exposed (1.5 - 5 min) to 10
M N-ethylmaleimide, a
change in permeability, apparently similar to that elicited by hormone on
the serosal side, was recorded.

At the same time, there was no change in

oxygen consumption, even in the presence of Na .

It seems in this case that

N-ethylmaleimide is disrupting the mucosal barrier without actually penetrating the cells.

Two other substances were found to mimic the action of

hormone, when added to the serosal side of the toad bladder.

Cyclic 3',5'-

AMP is a likely intermediate in the glucogenic action of epinephrine on
heart muscle, smooth muscle, and liver, and in the action of ACTH on the
adrenal cortex, as well as that of glucagon on liver (Sutherland and Rail,
1960).

Theophylline, moreover, is known to prevent the breakdown of cyclic
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3',5'-AMP to 5'-AMP.

These two substances, cyclic 3*,5*-AMP and theophyl-

line, can cause an increase in the water permeability and in the shortcircuit current of the toad bladder (Orloff and Handler, 1961). However
_3
the concentrations at which they are effective are high: 10
M cyclic
_2
_8
3',5'-AMP or 10
M theophylline, as compared with 10
M arginine vasopressin or 10
M arginine vasotocin.
When we say that the response of the toad bladder is specific to the
neurohypophyseal hormones, we must include not only the natural hormones,
all of which have activity, but many of their synthetic analogs as well.
In Table III, Column I, are listed a number of analogs of oxytocin.

In

Column II is the calculated toad bladder activity in units per mg, derived
from data of Rasmussen, assuming the value of 360 units per mg for oxytocin,
which is its activity in the frog bladder (Heller and Pickering, 1961).
These data should be taken as approximations only.

However, they do in-

dicate, qualitatively, the relative activities of these various analogs.
One can see limited trends in this list.

Increased basicity in position 8,

other residues remaining unchanged, seems to be correlated with increased
toad bladder and rat antidiuretic activity (arginine vasotocin>lysine vasotocin>oxytocin, and arginine vasopressin >lysine vasopressin>leucine vaso3
pressin (phe -oxytocin)), and partially correlated (only in the oxytocin
series and not in the vasopressin series) with decreased rat uterus activity.

But Boissonnas and co-workers (1961) caution against hasty

generalizations in this direction and present a counter-example.
more information than just the total activity is needed.

Obviously,

If the assay

method is such that the time course of the response is measureable, this
data, analyzed in terms of a simple model, would give a number of parameters for each analog and each assay instead of just one.

An analysis of

the time course of the response of the toad bladder to oxytocin will be
given in this thesis.

This analysis has not yet been applied to any analogs

other than oxytocin, but that different analogs can have different response
curves is shown in Figure 11 (Thorn, 1959).

Thorn compared the effects of

arginine-, lysine-, and leucine-vasopressin on the urine flow and urine osmolality is rats and dogs.

He observed that the response to lysine vaso-

pressin was characterized by a fast onset and a rapid decline as compared
with the response to arginine vasopressin. The response curve to leucine
3
vasopressin (phe -oxytocin) was similar to that of lysine vasopressin. (He

TABLE III
Activities of Analogs of Oxytocin
1 2 3 4
5
6 7 8 9
CyS.Tyr.Ileu.Glu(NH )-Asp(NH )-CyS-Pro-Leu-Gly(NH )

OXYTOCIN

II
Analog

III

IV

Toad bladder

Rat antidiuresis

(units per mg)

(units per mg)

ARG 8 (arginine vasotocin)

9000

80

40

LYS8(lysine vasotocin)

2250

24

78

(as derivative of oxytocin)

Rat uterus
(units per mg)

Oxytocin

360

9
Sarcosme 3 8
PHE , ARG (arginine vasopressin)

225

/3-MERCAPT0PR0PI0NIC1(desamino oxytocin)

41

PHE3, LYS (lysine vasopressin)

36

DES-(PRO7, LEU8, GLY9)(oxytocin ring amide)

26

VAL3-

10

PHE2-

8.6

0.5

32

1.1

30

20

0.7

20

3

PHE 2 3 8
PHE , PHE , LYS N-acetyl-

110

450

400

20

active

250

0.8

0

59

0.3
1.7

These values were calculated from data of H. Rasmussen giving the halfmaximal concentration in moles per liter, assuming a value of 360 units
per mg for oxytocin, which is its activity on the frog bladder according
to Heller and Pickering (1961).
Boissonnas et al. (1961). All values except those noted c.
Heller and Pickering (1961).
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Differences in the response of the rat to intra-venous

injections of arginine-, lysine-, and leucine-vasopressin.
The effect of arginine-vasopressin rose more slowly and
lasted longer than that of the other two analogs. (From Thorn, 1959)
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incidentally found more rat antidiuretic activity with leucine vasopressin
than with lysine vasopressin.

Compare Table III). The total duration of

the increase in urine osmolality was 30-40 min after arginine vasopressin
and 20-30 min after the other two preparations.
Some of the synthesized hormone analogs are inhibitory.

Table IV

(Berankova et al., 1961) summarizes the effects of the more potent of the
2
inhibitory analogs. Tyr (Me) -oxytocin caused no contraction of the isolated rat uterus at 1,000 times the concentration of the minimum effective
2
dose of oxytocin. However, phe -oxytocin contains considerable oxytocic
activity. Hence, methylation of the tyrosine hydroxyl group leads to an inhibition while total removal leads to a compound with somewhat decreased
2
activity. The inhibiting effect of Tyr (Me) -oxytocin in situ lasted about
one hour. The potent Inhibitor, Gly*Cys'-oxytocin has about 1 unit of avian
depressor activity per mg and about the same rat uterus activity (Boissonnas
et al., 1961).

One could certainly learn a great deal about the function of

the neurohypophyseal hormones if the anatomy of these inhibitions could be
uncovered.

Again, possibly some information would be gained by comparing the

kinetics of the response to active analogs in the presence and in the absence
of inhibitory analogs.

TABLE IV
Inhibition of the Effects of Oxytocin and Vasopressin (Berankova, 1961).

Ratio
Inhibitor:Hormone

% Inhibition

uterus in vitro

300-600 a

75-100%

oxytocin

avian depressor

300-600:1

75-100%

vasopressin

rat pressor

280-720:1

50%

oxytocin

uterus in vitro

50:1

50%

oxytocin

uterus in situ

250:1

partial

vasopressin

rat pressor

1875:1

50%

oxytocin

avian depressor

17:1

50%

Inhibitor

Hormone

Effect

n, 2,3
homo-Tyr
oxytocin
(decapeptide)

oxytocin

^-Glu(NH2) 4 oxytocin
2
Tyr (Me) oxytocin

Gly»Cys oxytocin
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F.

Inactivation of the Neurohypophyseal Hormones
After the injection of vasopressin, or following stimulation of the

release of endogenous hormone, antidiuretic material is found in the urine.
If vasopressin is injected intravenously into a conscious rat, about 10% of
the injected activity can be recovered from the urine (Dicker, 1961).

Thorn

(1959a) obtained urine from rats orally loaded with 5% sodium chloride.
Antidiuretic material was found in this urine, and this material had the following properties: the major part of it did not pass an ultrafilter; it wag
completely inactivated by sodium thioglycolate, and by trypsin and chymotrypsin, while pepsin and pancreatic carboxypeptidase had no effect on the
antidiuretic activity.

These findings confirm previous results in the dog,

that the antidiuretic material is excreted in association with a large molecule.

The significance of this is unknown.

The inactivation pattern of this

material, cited above, is the same as that of lysine- or arginine-vasopressin.
Since only a small fraction of injected or of endogenous antidiuretic
hormone activity appears in the urine, the major part must be inactivated by
various processes in the tissues and in the blood.

The kidneys and the

splanchnic area are certainly involved (Dicker, 1961), for removal of the
kidneys or the tying off of the coeliac and mesenteric arteries, or both, retarded considerably the rate of disappearance of hormone activity.

The blood

itself, however, does not seem to be involved in the inactivation (Heller,
1960), except in pregnant primates (see below).

Therefore, the rapid decay

of injected hormone activity in the circulation, with a half-life of the order
of 1 to 2 minutes in the rat and 5 minutes in dog and man is due to its dispersal into the extravascular space.

The liver and the kidneys seem to be

the main sites of removal, and these organs are thought to rapidly inactivate
these peptide hormones (Heller, 1960).
The in vitro inactivation of vasopressin and oxytocin has been studied.
Vasopressin is inactivated after incubation with slices, or homogenates, of
kidney, of liver, of spleen, and of duodenum, but not of muscle (Dicker, 1961).
Oxytocin and vasopressin are inactivated by homogenates of; several regions
of the brain, including the hypothalamus (Hooper, 1961).

Homogenates of human

placentae inactivate both oxytocin and vasopressin (Hooper, 1960); oxytocin
is inactivated mainly by the supernatant fraction, vasopressin by the mitochondria and the microsome fractions.

The "oxytocinase" and "vasopressinase"
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from this tissue is further differentiated by dissimilar responses to inhibitors and to variation in pH.

Smith and Sachs (1961) investigated the

inactivation of arginine vasopressin by rat kidney slices.

Oxytocin markedly

decreased the rate of loss of arginine vasopressin from the incubation mixture; at a ratio of concentrations of oxytocin to vasopressin of 20:1, the
rate was inhibited 50%.
The most thoroughly studied of all the inactivating systems is that
found exclusively in the plasma of pregnant women and some anthropoid monkeys.
An enzyme, which inactivates oxytocin irreversibly, appears in the blood of
women after the 16th day of pregnancy, and its activity increases until parturition, when the activity is 28 to 60 times as high as in the first month
(Semm, 1961).
placenta.

The origin of pregnancy oxytocinase is thought to be the

Its function is probably the prevention of premature uterine con-

tractions by maintenance of a heavily damped balance between oxytocin production and inactivation.

At birth there must be either an increase in

uterine sensitivity or a marked increase in oxytocin release, or both.

Oxy-

tocinase has been purified and characterized by Tuppy and his associates
(Tuppy, 1961, for review).

They demonstrated that oxytocinase acted on oxy-

tocin with the splitting of the cystinyl-tyrosine bond in that molecule (see
Table I). Synthetic substrates for aminopeptidases were also tested.
these was L-cystine-di-beta-naphthylamide (CDNA).

Among

Oxytocinase preparations

split many such substrates, but during purification, the biologically assayed
inactivation of oxytocin was always associated with the splitting of CDNA.
Moreover, the rise in oxytocinase activity during pregnancy was paralleled
by a similar rise in CDNAase activity.

Vasopressin is also inactivated to

a considerably increased extent by pregnancy sera.
than oxytocinase are probably also involved in this.

However, enzymes other
More will be said about

pregnancy oxytocinase in the discussion of my own results on the inactivation
of oxytocin.
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EXPERIMENTAL

The question we asked was this : We know that the neurohypophyseal
hormones have a profound effect on the toad bladder.

Can we isolate some

component of this tissue which will react with these hormones, this reaction
having physiological significance?

Of all the possible reactions of ex-

tracts with hormones, those that would cause inactivation of the hormones
would be the easiest to detect.

They would also, because of their generality,

be the most difficult to interpret.

There could be three modes of inacti-

vation: a change in the structure of the hormone, including denaturation;
binding of the hormone to some component of the extract; and the presence
in the extract of some factor inhibiting the physiological effect of the hormone.

Any or all of these could occur.

Needless to say, when cells are dis-

rupted, reactions that might have depended on fine structure will not occur,
and reactions that would not normally occur because of structural segregation
are likely to occur.

Despite these portended difficulties, the inactivation

of hormone by bladder homogenates was tested.

There was no question that

some form of inactivation would take place; but the extent, the specificity,
and finally, of course, the significance of such reactions were to be deter
mined or at least pondered.
The work will be presented in sections; the results of each section
will be preceded by the pertaining methods.
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A.

The Inactivation of Hormones by Toad Bladder Fractions

Methods
The toads were a Latin American species, Bufo marinus.

They were

obtained from the National Reagents Co., and were kept with access to water
and without feeding.

Males and females were used at first, but later,

females, because of their greater size, were used exclusively.

Individuals

weighed 200 to 400 gm.
The hormones used were prepared by Dr. Rasmussen from natural sources
by counter-current distribution and column chromatography.

One sample of

oxytocin and of oxytocin ring amide was obtained from Dr. du Vigneaud.
1.
0-4

C.

Preparation of fractions: All operations were carried out at

The general procedure was to pith a number of toads, to excise their

bladders into buffer, to mince the bladders, usually with a razor blade on
a wax plate, to homogenate, and then to centrifuge the homogenate.

The super-

natant was fractionated with ammonium sulfate, and the ammonium sulfate
fractions were passed through Sephadex G-25 (in lieu of dialysis).
In detail, at first the bladders were carefully homogenated by hand
in an all glass homogenizer.

The buffer used contained 0.25 M sucrose, 0.05 M

tris [tris (hydroxymethyl-) aminomethanej , 0.005 M versene [disodium ethylenediamine tetraacetate], and 0.04 M HC1, pH 7.0 (

Hall et al., 1960).

In all

later experiments, homogenization was in a Vir Tis "45" homogenizer at
moderate speed (setting 70) for 1 or 2 minutes.
tris, 0.005 M versene, and 0.04 M HC1, pH 7.0.

The buffer contained 0.05 M
The usual proportions were

one whole bladder per 4 ml of buffer, which was about 5 gm wet tissue per 100
ml homogenate.
The homogenate was then centrifuged at 700 x G for 10 minutes.

This

removed a great deal of the connective tissue, whole cells, and nuclei.

The

supernatant was filtered through sterile absorbent cotton to rid it of the
remaining strands of connective tissue, and was then centrifuged at 105,000 x
G for 30 minutes.

This supernatant fraction we will designate S.

The ammonium sulfate fractionation of S proceeded as follows: about
100 ml of S was stirred slowly as solid ammonium sulfate was gradually added
over a 5 minute period.

After 30 minutes the solution was centrifuged at
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35,000 x G for 15 minutes.

The sediment was taken up in tris-versene buffer,

and the supernatant was further fractionated by repetition of the above
steps.

A fraction is designated S(30-50), for instance, if it was pre-

cipitated between 30 and 50% saturation.

The per cent saturation is ac-

tually that at 20° C.
Ammonium sulfate fractions were distributed on a column of Sephadex
G-25 (Porath and Flodin, 1959).

Sephadex, as received from Pharmacia, was

screened between 120 and 200 mesh.
acid and allowed to swell.

The powder was stirred into 50% acetic

The suspension was then degassed by evacuation.

The gel was washed first with 40 volumes of water and then with 10 volumes
of buffer containing 0.01 M tris and 0.008 M acetic acid, pH 7.5.

This

buffer, which we will call tris-acetate buffer, was also used to elute the
column.

The gel was repeatedly stirred into a dilute suspension, allowed

to settle, and the fines decanted.

A dilute suspension was poured into the

column, and after a few centimeters x>f gel had settled, buffer was permitted
to run slowly through.

The bed, which had the final dimensions of 48 x 0.9

cm, was thus poured in two stages.

The column was washed with 200-300 ml

of tris-acetate buffer before use.
As a rule, 5-10 ml of ammonium sulfate fraction, with a protein concentration of about 5 mg per ml, was added carefully to the column.

When

the fluid reached the level of the top of the bed, elution with tris-acetate
buffer was begun.

The rate of flow was 15 ml per hour.

collected in a Resco Fraction Collector.

1 ml fractions were

The optical density of the fractions

at 280 m|i was determined in a Beckman DU Spectrophotometer.
of the column was 12 ml.

The void volume

Most of the absorbence at 280 m|_ was recovered in

tubes 13 through 21 (i.e., from 13 ml to 21 ml). These fractions were pooled
and designated by a D following the ammonium sulfate fraction designation;
e.g., S(50-70)D.
tube 35.

Ammonium ion and chloride ion were found to peak around

The purpose of this step was to prepare the ammonium sulfate

fractions for chromatographic investigation; hence the total salt content
was in this way decreased, and chloride ion, which would interfere with a
step to be described later (performic acid oxidation), was removed.

These

fractions as well as the undistributed ammonium sulfate fraction were stored

at -20° C.
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Three methods were used to determine protein concentration: the
turbidimetric method, the Lowry method, and the reading of optical density
at 280 m|_ directly as mg per ml (Layne, 1957).

It was the latter method

which was settled on and used routinely.
2.

Incubation of S fractions with hormone:

The actual composition

of the incubation mixtures will be given with the results.

In most of the

experiments, the hormone concentration in the mixture was about 1 \xg per ml.
In some experiments, however, the concentration was 100 |j.g per ml. For
-4
oxytocin, with a molecular weight of 1007, this is about 10
M. When Lcysteine or reduced glutathione (GSH) were added, they were dissolved shortly
o
before use. The incubation was either at room temperature, 24-25 C, or at
30 C. The time of incubation was usually 30 minutes, though at higher
hormone concentrations it was generally 1 hour.

At the end of the incu-

bation period, 2 ml aliquots of the incubation mixture were added to 3 assay
tubes, each containing 25 ml of Ringer's.

At the higher hormone concen-

trations, the incubation mixture was diluted before aliquots were taken.
Controls, with buffer replacing the S fraction, were always run simultaneously.
3.

Assay of hormones:

The response of the toad bladder was used as

the basis for the assay (Bentley, 1958).

As was described in the Introduction,

the neurohypophyseal hormones cause a marked increase in the water permeability of the bladder.

This is measured by tying a half-bladder up like

a bag, with dilute Ringer's or water inside and with Ringer's outside.

Water

flows out, and the weight of the half-bladder plus the glass insert to
which it is attached plus the inside solution decreases.
equal to the water loss.

The decrease is

The apparatus used is shown in Figure 12.

The actual procedure was as follows:
bladders removed into Ringer's.

6 toads were pithed and their

The Ringer's contained 110 mM NaCl, 1 mM

NaHC0 o , 1 mM KoHP0., 0.2 mM KH_P0 , and 2 mM CaCl , pH 7.6. The bladder
3
2
4
2 4
—
consists of two bag-like halves, joined at the neck. Each of the halves was
separately excised, and they were used in different groups. Each halfbladder was mounted on an insert, tied with surgical silk, and filled with
3 ml of 1/5 Ringer's or water.

The insert and half-bladder were then placed

in 25 ml of Ringer's in an assay tube.

The half-bladders were mounted with

the serosal side out, mucosal side in, as in situ.

The serosal bath was

aerated and mixed by a stream of air entering at the bottom of the tube.

Figure 12.

The toad bladder assay apparatus.

diagrammatic representation of one assay tube.

The insert shows a
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The half-bladders were weighed by drawing them carefully up the side
of the assay tube so as to remove excess fluid, and by suspending the insert from the beam of a Sartorius balance.

The weight was read to 1 mg.

The bladders were out of solution 30 seconds or less.

There were two or

three 20 minute control periods during which the bladders were weighed at
20 minute intervals.
baths.

Then the test solutions were added to the serosal

The resting loss was normally about 1 mg per minute or less.

Leaks

were detected in the control period as a large loss in weight.
After addition of the test and control solutions to the serosal baths,
weighing was continued for two or three 20 minute periods.

The response of

a half-bladder was given as the loss after addition minus the loss before
addition, all in mg per hour.

The responses of the half-bladders receiving

the same test solution were averaged.
the standard deviation of the mean.

The results are given as the mean +•
In many experiments the test responses

are compared with the control responses directly, without converting them
into hormone concentrations.

In these, a test response not significantly

different than the control response is taken to indicate no inactivation of
hormone/ a test response not significantly different from zero is taken to
indicate complete inactivation, and responses between zero and the control
response are taken to indicate partial inactivation.
A more quantitative design was also used.
dose-response curve was determined.

In this, a standard log

The test responses and control responses

were compared with this curve, and the difference in concentration of hormone was calculated.

Two types of error were involved in these results,

the error in the response and the error in the standard curve.

The signi-

ficance of the difference between the control assay and the test assay was
calculated only from the error in the response; i.e., it was determined
whether the responses were significantly different.

But the error in the

difference in the log concentration depended on both errors.

The standard

error of the final result, the difference in log concentration, was estimated as the square root of the sum of the squares of the separate standard
errors.

In practice, the best design was one in which two dose levels were

used for both the test assay and the control assay.
with three half-bladders.

Each dose was assayed

Each individual response was compared with the
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standard curve, and the individual log doses were averaged.

When the log

concentration is converted to the concentration, the standard error becomes
a factor.

The t-test was used to test significance.

Results
Originally, the ability of bladder extracts to inactivate AVP was
tested.

It was found that AVP was inactivated by the total bladder homo-

genate, by the post-nuclei supernatant (i.e., after 700 x G for 10 minutes),
by the post-mitochondrial supernatant (i.e., after 10,300 x G for 15
minutes), and by the post-microsomal supernatant (i.e., after 105,000 x G
for 30 minutes).

These results showed that the particle-free supernatant

contained a large part of the inactivating potency of the bladder homogenate, and it was this supernatant, called S, which was regularly used.
Figure 13 shows the inactivation of AVP by S.

AVP incubated with S

shows almost no activity (I), while AVP incubated with buffer shows full
activity (II). An equivalent dose of AVP was finally added to the same
half-bladders as (I). It is seen that with this additional dose of AVP,
these same bladders showed full activity (III).

The two controls, (II) and

(III), were not significantly different.
The time course of the inactivation of AVP was determined in two
experiments.

Different preparations of S were used in these experiments.

Figure 14 shows the results of these experiments.
actual rate of loss of water.
log dose of hormone.

We have plotted the

This, as we shall see, is proportional to the

Hence, a linear decrease in the rate of loss of water

with time would correspond to an exponential decrease in hormone activity.
Although there is scatter in the data (one of the control values is quite
high), a straight line has been drawn.

On the basis of this line we can

say that the hormone is inactivated under these conditions with a half life
of about 10 minutes.

After 30 minutes activity is hardly detectable.

o
There was difficulty in storing S. Storage for a few days at -20 C
o
or overnight at 2-4 C resulted in a loss in inactivating potency. It was
found, however, that this loss in potency could be restored with cysteine
or reduced glutathione. Figure 15 illustrates the results of an experiment
in which S, which had been stored for a few days at -20° C, was incubated
with AVP, and with (I) or without (II) added cysteine.

With cysteine, there

lOOOr
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The inactivation of AVP by fraction S.

The Incubation mixtures contained:
(10 jig/ml);
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(II) 9 ml buffer and 1 ml AVP.

30 minutes at 25

C.

(I) 9 ml S and 1 ml AVP
These were incubated for

2 ml was added to each bladder.

dose of AVP was added to the same bladders as (I).
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The time course of the inactivation of AVP by S.

The incubation mixtures contained: (I) 9 ml S and 1 ml AVP
(10 ug/ml); (II) 6.7 ml S, 0.1 ml 0.1 M cysteine, and 0.2 ml AVP
(40 pg/ml). 2 ml was added to each bladder.
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The effect of cysteine on the activity of stored S.

The incubation mixtures contained:

(I) 6.3 ml S (stored 2 days

at -20° C), 0.7 ml AVP (10 ug/ml), and 0.1 ml
6.3 ml S, 0.7 ml AVP; and
cysteine.
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Figure 15.

(iW)

(n«3)

(II)

(III) 6.3 ml buffer, 0.7 ml AVP, and 0.1 ml

All were incubated at 25

to each bladder.

0.1 M cysteine;

C for 30 minutes.

2 ml was added

(IV) and (V) represent the mean of a number of experi-

ments in which AVP was incubated with buffer and with (IV), and without
(V), added cysteine.
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was complete inactivation of AVP; without cysteine, there was partial inactivation.
(III).

The control, with buffer, cysteine, and AVP, was fully active

In the same figure, a number of controls are compared in which AVP

is incubated with (IV) and without (V) cysteine.
difference (P>0.4) between these responses.

There is no significant

Hence, cysteine alone neither

inactivates nor potentiates the hormone.
The heat-lability of S was investigated. Aliquots of S were preo
o
heated to 50 C and to 70 C for 5 minutes. They were cooled quickly to
room temperature and incubated with AVP, and the incubation mixture assayed.
Figure 16 summarizes these results.
hormone (I). S, heated to 50
(II); and S, heated to 70

Unheated S completely inactivated the

C, only partially inactivated the hormone

C, did not inactivate the hormone at all (III).

The difference between II and III was not quite significant (0.05<P<0.1) .
We may conclude that the hormone-inactivating potency of S is increasingly
destroyed by temperatures above 50

C.

It was found, moreover, that this

loss of potency could not be restored with cysteine.
Since the inactivating potency of S was in some cases enhanced by
cysteine, it was thought possible that free sulfhydryl groups might be involved in the action of S.
(NEM) on S was studied.

For this reason the effect of N-ethylmaleimide

NEM reacts quickly with sulfhydryl groups.

It is

not, however, specific for these and reacts also with amino groups, and
_3
with imidazole (Smyth et al., 1960). S was treated with 10
M NEM for 20
minutes at 25 C. Cysteine was added to react with excess NEM, and the
treated S was incubated with AVP.

Figure 17 summarizes these results.

NEM-treated S showed a complete loss of hormone inactivating potency (I).
Untreated S, on the other hand, completely inactivated the added hormone
(II); i.e., it had full potency.

Though not shown in this figure, NEM,

after reaction with cysteine, had no effect on the bladder.
The action of S on some of the other hormone analogs was tested.
S completely inactivated approximately equally potent doses of arginine
vasopressin (AVP), arginine vasotocin (AVT), oxytocin, lysine vasopressin
7
8
9
(LVP), and des-(pro , leu , gly )-oxytocin (oxytocin ring amide). Figure
18 summarizes these results. The results do not necessarily indicate a
lack of specificity of the inactivation.

These hormones have quite similar

structures (see Table 3 ) , especially around the disulfide bond.
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The inactivation of S by N-ethyimaleimide.

The incubation mixtures contained:
0.07 ml

0.1 M NEM, and 0.07 ml

0.7 ml AVP;
0.07 ml
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Buffer.AVP

(I) 6.3 ml S, 0.7 ml AVP,

0.1 M cysteine;

(II) 6.3 ml S and

(III) 6.3 ml buffer, 0.7 ml AVP, 0.07 ml

0.1 M cysteine;

0.1 M NEM, and

(IV) 6.3 ml buffer and 0.7 ml AVP.

was preincubated with S for 20 minutes.
After 10 minutes AVP was added.

The NEM

Cysteine was then added.

Incubation was at 25° C for 30 minutes
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The inactivation of hormone analogs by S.

The incubation mixtures contained 6.3 ml S and 1.4 mM cysteine.
The Incubation was at 25

C for 30 minutes.

The concentrations of the

analogs in the control assays Were: AVT, 0.00042 ug/ml; oxytocin, 0.042
pg/ml; AVP, 0.084 jig/ml; LVP, 0.17 ug/ml; and oxytocin ring amide, 0.27
Ug/ml.
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Next, we attempted a partial purification of S by ammonium sulfate
fractionation.

In these, and all following experiments, oxytocin was used

as the substrate.

Our first fractionation revealed that among the three

fractions, S(0-30), S(30-60), and S(60-85), the first had no detectable inactivating activity, while the latter two were both active.

It was also

found that activity was considerably reduced in the absence of either
cysteine or reduced glutathione, and one of these was always added to the
incubation mixture.

Three further fractions were then prepared:

S(50-70), and S(70-85).

S(30-50),

They were all found to contain some activity, as

was consistent with the previous results; but upon dilution, the fraction
S(50-70) was seen to contain the most activity.
results.

Figure 19 summarizes these

Two experiments are represented, one in which 3 ml of each fraction

was added to the incubation mixture (final volume 6 ml), and another in
which 1.5 ml of each fraction was added.

All fractions completely inacti-

vated the hormone at the higher concentration, but when they were diluted
two times, the greater inactivating potency of S(50-70) became apparent.
In order to better quantitate the hormone assay, a standard curve,
of the loss of water in mg per 40 minutes versus the log of the dose of
hormone, was determined (Figure 20). A straight line was fitted for the
range 0.004 ug per ml to 0.100 ug per ml.
(Gaddum, 1953).

The index of precision was 0.26

The results of each assay were compared with the standard

curve as described in the Methods.
Two experiments, in which different preparations of S(50-70) were
used, gave the rate of inactivation of oxytocin as (I) 30 ug per mg protein
-9
per hr and (II) 41 jig per mg protein per hr (1 pg oxytocin equals 10
moles).
The standard error of the log concentration in both these cases was about
0.2; in other words, these results each vary by a factor of about 1.6
(e.g. , for (I), from 19 to 48 jig per mg per hr) .
The rate of inactivation of oxytocin by the distributed fraction,
S(50-70)D, was also determined.
in the absence of cysteine.

This fraction showed considerable activity

With no cysteine present in the incubation

mixture, the rate was 16 ug per mg per hr, with an error of a factor of 1.5.
-4
The initial substrate concentration in these experiments was 10
M, or
100 ug per ml, and the final concentration was less than 50 ug per ml.
Incubation was at 30

C for 2 hours.
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The inactivation of oxytocin by ammonium sulfate fractions of S,

The incubation mixtures contained:
3 ml (or 4.5 ml) buffer, 0.2 ml

(I) 3 ml (or 1.5 ml) S(30-50),

0.05 M GSH, and 0.8 ml oxytocin (5 pg/ml);

(II) 3 ml (or 1.5 ml) S(50-70), 3 ml (or 4.5 ml) buffer, 0.2 ml GSH, and
0.8 ml oxytocin;

(III) 3 ml (or 1.5 ml) S(70-85), 3 ml (or 4.5 ml) buffer,

0.2 ml GSH, and 0.8 ml oxytocin;
oxytocin.
bladder.

(IV) 6 ml buffer, 0.2 ml GSH, and 0.8 ml

Incubation was at 26° C for 30 minutes.

2 ml was added to each
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Figure 20. A standard log-0 dose-response curve for oxytocin.
S ss 219, b = 830, and X - 0.26, where s is the square root of the
sum of the variances of each point divided by the number of degrees of
freedom, b is the slope, and A is the index of precision, equal to s/b.
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The results of this section suggested that there might be present
in S, and in its ammonium sulfate fractions, some enzyme, or enzymes, which
inactivate the neurohypophyseal hormones.

To test this hypothesis further

we tried to determine whether a particular peptide bond of the hormone
molecule was split.

If this enzyme acted as an aminopeptldase and split

th© bond between the N-terminal half-cystinyl residue and the tyrosyl
residue, as has been shown to be the case for pregnancy serum oxytocinase
(see Introduction), then performlc acid oxidation of the disulfide bond of
the split product would liberate cysteic acid (Tuppy and Nesvadba, 1957).
In the next section are presented the results of such experiments.
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B.

Chromatographic Examination of Performic Acid Oxidized Incubation
Mixtures

Methods
S(50-70) was distributed on Sephadex G-25, as described above, to
remove residual ammonium sulfate and to change from tris HCl-versene buffer
to tris-acetate buffer.

The presence of chloride ion can cause side

reactions during performic acid oxidation (Hirs, 1956).

The distributed

S(50-70) is called S(50-70)D.
The incubation mixtures contained (I) 0.5 ml S(50-70)D and 0.5 mg
oxytocin, (II) 0.5 ml S(50-70)D, and (III) 0.5 ml tris-acetate buffer and
0.5 mg oxytocin.

These were incubated at 30

C for 4 hours.

bation, the incubation mixtures were cooled quickly to 0
chloroacetic acid (0

After incu-

C, and 30% tri-

C) was added to 5% final concentration.

The pre-

cipitate was spun off, and the supernatant extracted 3 times with 3 volumes
of fresh ethyl ether to remove the TCA (Smith and Sachs, 1961).

The ether

was removed in a stream of nitrogen.
Performic acid was prepared by mixing 9 volumes of 98% formic acid
and 1 volume of 30% hydrogen peroxide.

This solution was kept at 25

C

for 1 hour before it was used.

The performic acid solution was pipetted
o
into reaction vessels and cooled to -15 C in a water-ice-ethanol bath.
The processed incubation mixtures were cooled to 0 C and added to the
performic acid solutions.
point was about 0.4 ml.
solution.

The volume of the incubation mixtures at this

This was added to 2 ml of the performic acid

The oxidation continued for 90 minutes at -15

C.

Then 20 ml

of ice cold water was added to each reaction vessel, the contents were
quickly frozen in dry ice-acetone, and were lyophilized.

The residue was

redissolved and relyophilized.
Paper chromatography was performed on Whatmann #1.

The solvent

system contained n-butanol: acetic acid: water in the volume proportions
100:22:50.

This forms a single phase at room temperature.

The lyophilized

residue was taken up in 0.05 ml water and applied to the paper in 0.005 ml
aliquots, with drying in cool air between applications.

Chromatography

was in the descending direction and for 18 or 19 hours, in which time the
solvent front moved about 40 cm.

The chromatograms were dried in a hood
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for a few hours.

When dry, they were sprayed with ninhydrin (0.3% in

ethanol, Sigma), and the color was developed overnight at room temperature.
The oxytocin moved as a single spot in this solvent system.

Results
Figure 21 is a tracing of a chromatogram of protein-free incubation
mixtures before performic acid oxidation.

The position of oxytocin in two

of the controls, (II) and (IV), is indicated by an arrow.

The second spot

in (IV) was due either to the buffer or to the treatment with TCA, since
it did not appear if oxytocin, in water solution, was applied directly.

A

spot corresponding to oxytocin did not appear, however, in the incubated
mixture of S(50-70)D and oxytocin (I). Moreover, there was a general increase in ninhydrin positive material in (I) which did not occur either in
the same mixture kept at 0

C during the incubation period (II), or in

S(50-70)D alone, incubated for the same time and at the- same temperature
as (I). There is a second, faster-moving spot in the incubated mixture of
buffer and oxytocin, treated in the same way as (I), but there is no appearance of slower moving spots as in (I). We can conclude that oxytocin is
being removed or altered during incubation with S(50-70)D, and that this
process coincides with an increase in ninhydrin positive material.
Figure 22 is a tracing of a chromatogram of the protein-free incubation mixtures after performic acid oxidation.

The positions of cysteic

acid (V) and of performic acid oxidized oxytocin (IV) are shown.

It is

seen that an oxytocin spot did not appear, and that instead ninhydrin
positive material appeared at approximately the position of oxidized oxytocin in (III) and (I). In (I), again, there was an increase in ninhydrin
positive material compared to S(50-70)D incubated without oxytocin (II).
In particular, a dense spot appeared in (I) at the position of cysteic
acid (marked by an arrow).

A much lighter spot appeared at the same

position in (II). Similar light spots appeared, even before oxidation, in
the comparable mixtures (I) and (III) in Figure 21.

They could be due to

the presence of small amounts of cysteic acid in S(50-70)D.

If the dense

spot is due to cysteic acid, we may conclude, as explained at the end of
section I, that the bond between the N-terminal half-cystinyl residue and
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the tyrosyl residue of oxytocin was cleaved.

Moreover, the general increase

in ninhydrin positive material suggests that other bonds of the oxytocin
molecule also have been split.
Evidence of a different nature, supporting the hypothesis that an
enzyme is present in our S fractions, which cleaves N-terminal half-cystinyltyrosyl bonds, is presented in the next section.

There we review our study

of the action of toad bladder extracts on two synthetic substrates.
these, L-cystine-di-beta-naphthylamide, resembles oxytocin

One of

and its hormone

analogs in possessing an N-terminal cystinyl-peptide linkage.

We shall see

that this bond is readily split by our hormone inactivating fractions.
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C

The Splitting of Synthetic Substrates

Methods
We are concerned in this section principally with the action of S
and its fractions on two substrates, L-cystine-di-beta-naphthylamide (CDNA),
and L-leucine-beta-naphthylamide (LNA).

The first of these, CDNA, is

sparingly soluble at neutral pH, and a saturated solution contains about
—5
6.8 x 10
moles per liter. This was, then, the highest concentration of
this substrate which we could obtain in our incubation mixtures. In many
cases an amount in excess of saturation was added, so that the concentration
of substrate remained constant throughout the incubation.

CDNA was dis-

solved either in dilute HC1 or in 50% methoxyethyleneglycol (methyl cellosolve) . A convenient stock solution was 1 mM CDNA in 2 mM HC1.

LNA«HC1

was readily soluble in water, and was made up in 1 to 4 mM concentrations.
The substrate solutions were stored in amber glass bottles at 2-4

C.

Beta-naphthylamine was dissolved in 2 mM HC1 at a concentration of 0.4 mM,
o
and was stored in an amber glass bottle at 2-4 C.
The incubation mixtures, made up in duplicate, contained 0.25 ml
enzyme fraction, 0.25 ml substrate, and 0.5 ml buffer (the same as that in
which the enzyme fraction was dissolved, either tris-acetate or trischloride-versene, except in the pH studies, in which phosphate buffer was
used).
same.

Often smaller volumes were used, but the proportions remained the
The incubation was usually at 30

C.

The pertinent details of the

incubation will be given with the results.
Beta-naphthylamine, released by cleavage of the peptide bond, was
assayed by the method of Tuppy and Nesvadba (1957), with slight modifications.

Following incubation, 1 ml 10% TCA was added to the 1 ml volume

of the incubation mixtures.

For smaller volume incubation mixtures, all

other volumes were proportionally decreased.

The TCA-precipitated protein

was centrifuged off, and 1 ml of the supernatant was added to 9 ml of a
mixture of 2 volumes of 0.36 M HC1 and 1 volume of acetone.
following additions were made exactly 3 minutes apart:

Then the

1 ml 0.1% sodium

nitrite, 1 ml 0.5% ammonium sulfamate, and 1 ml 0.1% N(l-naphthyl)ethylenediaminedihydrochloride.

Following addition, the solutions remained

in stoppered flasks for 45 minutes at room temperatures.

During the

addition of the reagents and the development of the color, strong daylight
was excluded.

32

The optical density at 565 m(-i was determined in a Coleman Jr.
Spectrophotometer, using matched cuvettes.

After 45 minutes, the color was

still slowly changing, so that each sample was read exactly at the same
time following the addition of the last reagent.

The blanks were incubation

mixtures containing buffer in place of enzyme which were similarly processed as was the standard which contained buffer and beta-naphthylamine.
The concentration of beta-naphthylamine in a sample was calculated as the
ratio of the optical density of the sample over the optical density of the
standard, times the concentration of beta-naphthylamine in the standard.
Duplicates were averaged.

The average is given + the average deviation.

The standard curve of optical density versus concentration of betanaphthylamine was linear.

Results
The CDNAase activity of S and of its ammonium sulfate fractions is
shown in Table V.

There we have given the mean specific activity + the

standard deviation of the mean of a number of different preparations.

The

pattern of activity is the same as that of the fractions which were obtained from a single preparation of S. S had a specific activity of about
-7
0.2 x 10
moles per mg per hr. The ammonium sulfate fraction, S(50-70)
-7
had about twice the specific activity of S, about 0.4 x 10
moles per mg
per hr, while S(0-50) and S(70-85) had each less than 25% of the specific
-7
activity of S(50-70), about 0.1 x 10
moles per mg per hr. This, of
course, represents the same pattern of activity found in the inactivation
of oxytocin. Distribution on Sephadex increased the specific activity of
-7
S(50-70) about 50% to 0.6 x 10
moles per mg per hr, while the specific
activity of S(0-50)D and S(70-90)D remained low. The total activity recovered in S(50-70)D was about 50% of that of S.
A less broad ammonium sulfate fractionation resulted in a fraction,
S(60-70)D, with a higher specific activity than S(50-70)D.

However, the

recovery of total activity was not good and S(50-70)D was the best preparation regularly used.
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TABLE V
The Rate of Hydrolysis of CDNA by Fractions of S

The values are given + the standard deviation of the mean, n is the number
of different preparations [s(0-50) and S(0-50)D were different preparations]
The incubation mixtures contained S-fraction, buffer, and CDNA in excess
of saturation. Incubation was for 30 min or 60 min at 30° C.

Fraction

Mean Rate
10

moles
loles /5-naphthylam
/5-naphthylamine liberated
per hour per mg fraction

S 0.18 + .07 (n = 3)
S(0-50)

0.07

(n = 1)

S(50-70)

0.35 + .08

(n » 3)

S(70-85)

0.08 + .04

(n = 2)

S(0^50)D

0.02

(n = 1)

S(50-70)D

0.60 + .06

(n = 4)

S(70-90)D

0.01

(n = 1)

S(60=70)D was used however in an attempt to determine approximately
the V
and K of this preparation. The range of substrate concentrations
max
m
which could be tested unfortunately was narrow. CDNA precipitated above
-5
-5
6.8 x 10 , and below 2 x 10
M the initial velocity could not be determined because of the limitations in the sensitivity of the assay. Moreover, the enzyme preparation was not completely stable, and was of course
highly impure.

Nevertheless, from the data plotted in Figure 23 we can

gain some idea of the reaction constants.

The plot of the reciprocal

initial velocity versus the reciprocal substrate concentration was linear
-7
except for one point. On the basis of the line drawn, V
= 1.7 x 10
max
moles per mg per hr and K = 8.5 x 10
moles per liter.
m
One other difficulty in the interpretation of these kinetic data
should be mentioned. There are two susceptible bonds per molecule of CDNA.
The second bond is certainly attacked, since with sufficiently long incubation periods the molar concentration of beta-naphthylamine became greater
than the initial molar concentration of CDNA.
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Figure 23. A Lineweaver-Burk plot of the CDNAase activity of S(60-70)D.
The incubation mixtures contained 0.25 ml S(60-70)D, 0.5 ml trisacetate buffer, pH 7.4, and 0.25 ml CDNA of different concentrations.
_7
The rates after 5 and 10 minutes were averaged. V
= 1.7 x 10
moles
max
_6
per hr, and K m a 8.5 x 10~ moles per liter.
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We can conclude thus far that CDNA is split by S and its fractions,
that the fractionation of CDNAase activity and of oxytocin inactivating
activity is similar, and that the actual specific activities are of the
same magnitude; e.g., for S(50-70)D, the CDNAase activity is about
-7
0.6 x 10
moles per mg per hr and the oxytocin inactivating activity is
-7
about 0.2 x 10
moles per mg per hr.
The specific CDNAase activity appears to be higher in toad bladder
homogenates, and especially homogenates of the mucosal cells of the toad
bladder, than in homogenates of other tissues of the toad (Table VI). In
all cases the particle-free supernatant fraction of the tissue homogenate
was used.

Mucosal cells, free of supporting tissue, were obtained by

stretching half-bladders, mucosal side out, over a plastic centrifuge tube
and by gently scraping the mucosal surface with a clean razor blade.
scrapings were washed off into tris-chloride-versene buffer.

The

They appeared

in the phase microscope to consist entirely of sheets of epithelial cells.
A supernatant fraction was then prepared from a homogenate of these cells.
Supernatant fractions were also prepared of the heart, of the egg mass, and
of the liver.

The specific activity of the mucosal cell supernatant was

almost twice the mean specific activity of the whole bladder supernatant.
This clearly suggests that the CDNAase activity is located principally in
the epithelium and not in the smooth muscle or blood vessels of the lamina
propria (compare Figure 7).

Of the other tissues, heart appeared to contain

less but comparable specific activity, while that of the egg-mass and of
liver was considerably less.

Of course, the total activity of the liver

would still be greater than that of the bladder.

We can conclude that the

specific CDNAase activity of the bladder epithelium is considerable and is
probably greater than that of other tissues of thetoad.
As was the case with the oxytocin inactivating activity, cysteine
was found to stimulate CDNAase activity.

The effect of 1 mM cysteine on

the CDNAase activity of two preparations of S(50-70) and of yet another
preparations of S(50-70)D is shown in Table VII.

Cysteine, it appears,

increased the specific activity of S(50-70) about 80% and of S(50-70)D 60%.
The effects of N-ethylmaleimide (NEM) , of iodoacetic acid (IA), and
of oxidized glutathione (GSSG) were also determined.

NEM had been shown

to inhibit the oxytocin inactivating activity of S (see section A ) .

IA will

TABLE VI
The Specific CDNAase Activity of Supernatant Fractions
of Various Tissues of the Toad
CDNA was in excess of saturation. Incubation was at 30 C for 2 hours,

S Fraction of

Specific CDNAase Activity
-7
10
moles ^?-naphthylamine liberated
per hour per mg fraction

Whole bladder

0.18 + .07

Mucosal cells of bladder

0,33 + .03

Heart

0.11 + .01

Egg mass

0.05 + .01

Liver

0.03 + .01

TABLE VII
The Effect of Cysteine on the CDNAase Activity
of S(50-70) and of S(50-70)D
Cysteine was present in the incubation mixture in the concentrations indicated. CDNA was present in excess of saturation. Incubation was at 30 C
for 1 hr.
Fraction

Cysteine
Concentration

Specific Activity

Ratio

10 moles /^-naphthylamine
liberated per hour
per mg fraction

S(50-70)

0
1 mM

S(50-70)

0
1 mM

0,,41 + .04
0 ,78 + .03

1.9

S(50-70)D

0
1 mM

0 .47 + .01
0 .74 + .05

1.6

*

0.33
0.60

The three preparations were from different sources.

1.8
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react with SH groups with the liberation of hydroiodic acid, and GSSG will
form mixed disulfides with free SH groups.

These reagents, in 1 mM con-

centration, caused considerable inactivation of the CDNAase activity of
S(50-70).

Table VIII summarizes these results.

NEM and IA were preincu-

bated with S(50-70) for 20 minutes; then an equivalent amount of cysteine
was added to react with excess NEM and IA.
and the incubation begun.

5 minutes later CDNA was added

GSSG was added at the beginning of the incubation.

The activation by cysteine and the inactivation by sulfhydryl reagents
suggests the participation of a sulfhydryl enzyme in the splitting of CDNA,
as in the inactivation of oxytocin.

However, NEM and IA can react with

other groups, such as the imidazole of histidine, while GSSG can possibly
act as a competitive inhibitor.

Nevertheless, that a sulfhydryl enzyme is

responsible for both the CDNAase and the oxytocin inactivating activities
is an attractive working hypothesis.

TABLE VIII
The Inhibition of the CDNAase Activity of S(50-70)
by Sulfhydryl Reagents
1 mM NEM and IA were preincubated with S(50-70) 20 minutes; then cysteine
was added to 1 mM. After 5 minutes, CDNA was added in excess of saturation.
1 mM GSSG was added with CDNA. Incubation was at 30° C for 2 hours. NEM N-ethylmaleimide, IA _? iodoacetic acid, and GSSG - oxidized glutathione.

Inhibitor

Specific Activity
10

moles /5-naphthylamine
liberated per hour
per mg fraction

Per Cent
Inhibition

None

0.41 + .04

NEM

0.25 + .01

40%

IA

0.15 + .01

65%

GSSG

0.19 + .01

55%
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Further evidence, supporting the view that a single enzyme is responsible for the inactivation of oxytocin and the hydrolysis of CDNA, is
that oxytocin inhibited the hydrolysis of CDNA by S(50-70)D.

Oxytocin,

present in the incubation mixture in the concentration of 0.1 mM, inhibited
by 30% the rate of hydrolysis of CDNA present in excess of saturation (i.e.,
-5 v
o
at constant concentration of 6.8 x 10
M) . The incubation was at 30 C
for 30 minutes. In another experiment, 0.75 mM oxytocin inhibited the
CDNAase activity of S(50-70)D about 40%.

In this case, however, the incu-

bation was longer, 2 hours, during which time the concentration of oxytocin
was probably considerably reduced, while the concentration of CDNA, present
in excess of saturation, was constant.

We will return to this inhibition

by oxytocin when we consider its effect on LNAase activity.
The specificity of the hydrolytic activity of the fractions of S was
then investigated.

Two other substrates were tested, principally LNA, and

also D,L-alanine-beta-naphthylamide (ANA).

The specific ANAase activity

was found to be of the same magnitude as the specific CDNAase activity.
was not investigated further.

It

The LNAase activity was investigated exten-

sively and compared in many experiments with the CDNAase activity.

In

experiments in which less than 25% of the total substrate was split, the
-7
mean specific CDNAase activity of S(50-70)D was 0 . 6 + 0 . 1 10 moles per
-7
mg per hr, and the mean specific LNAase activity was 5 . 3 + 0 . 6 10 moles
per mg per hr. The mean ratio of LNAase to CDNAase activity was 8.5. The
_3
substrate concentrations were 10
M LNA, and CDNA in excess of saturation.
The incubations were at 30 C for 30 minutes.
Among the fractions S(0-50)D, S(50-70)D and S(70-90)D, all prepared
at the same time, S(50-70)D contained the highest specific LNAase activity
and, as before, the highest specific CDNAase activity as well (Table IX).
In these experiments, the incubation was for 1 hour so that low specific
activities could be detected.
centration, but not in excess.

Also, CDNA was present at saturating conAs a result, nearly all the substrate,

both LNA and CDNA, was used up in the incubation with the most active
fraction S(50-70)D.
mined was low.

Hence the specific activity of this fraction as deter-

Nevertheless, the specific activity of S(50-70)D was still

considerably greater than that of the other two fractions.

Clearly most

of the LNAase activity, together with the CDNAase activity, was in S(50-70)D.
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TABLE IX
The LNAase and CDNAase Activities of Fractions of S
_5
The initial substrate concentrations were CDNA, 6.8 x 10
and LNA, 1.25 x
10~"4 M. Incubation was at 30° C for 1 hr. In the incubations with
S(50-70)D, both with LNA and with CDNA, nearly all the substrate was split
*
Fraction

Protein

Substrate
-,n~7

.
in Fraction

10

J

S(0-50)D

mg
97

S (50-70) D

104

CDNA
LNA

S(70-90)D

84

CDNA
LNA

*

Specific Activity

Recovered

CDNA
LNA

•*

A

I-J-I. i

moles P -naphthylamine
, ..
.
,
liberated per hour
per mg fraction
0.02 + .01
0.16 + .01
>0.24
>0.40
< 0.01
0.06 + .01

These fractions were prepared from a single preparations of S.

The dependence of the CDNAase and of the LNAase activities of
S(50-70)D on pH may be compared in Figure 24.

The pH curves for these two

substrates appear quite similar, with a maximum near pH 7.0.

The curve

for LNAase activity would have been steeper at higher substrate concentrations, since at the maximum rate nearly all of the available substrate
was split.
The heat inactivation of the CDNAase and of the LNAase activity of
S(50-70)D was then studied.
60

C or 70

Aliquots of S(50-70)D were heated to 50

C or

C for 3 minutes, cooled for 1 minute in an ice-bath, and then

incubated at 30

C for 30 minutes with CDNA and with LNA.

both activities was slight at 50° C and complete at 70

C.

Inactivation of
The two

activities were then compared after heating aliquots of S(50-70)D to temperatures between 50

C and 60° C (Table X).

The results showed a pro-

gressive inactivation of both activities, -30% at 52.5° C, -55% at 55° C,
o
and -75% at 57.5 C, in which the ratio of the two activities, however,
remained nearly constant.
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Figure 24.

The pH dependence of the CDNAase and of the LNAase

activity of S(50-70)D.
The incubation mixtures contained 0.1 ml S(50-70)D, 0.2 ml
phosphate buffer, and 0.1 ml substrate.
5

The initial concentration

of CDNA was 6.8 x 10~ M, and of LNA, 1.25 x 10" 4 M
was at 30

C for 30 minutes.

Incubation
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TABLE X
The Relation Rates of Hydrolysis of CDNA and of LNA
following Partial Heat Inactivation of S(50-70)D
The incubation mixtures contained 0.1 ml S(50-70)D (treated as indicated),
0.2 ml phosphate buffer, and 0.1 ml substrate; the pH was 7.0; the initial
substrate concentrations were: CDNA, in excess of saturation; LNA, 1 mM.
Incubation was at 30° C for 30 minutes.

Pre-heat
Temperature

Substrate
10

-

LNA
CDNA

52.5° C

LNA
CDNA

55.0° C

LNA
CDNA

57.5° C

Specific Activity
_
/i
... _
moles /L?-naphthylamine
liberated per hour
per mg fraction

-7

LNA
CDNA

Ratio
_...
LNAase
CDNAase

4.33
0.57

7.6

2.95
0.39

7.6

1.90
0.24

7.9

1.19
0.15

7.9

The evidence thus far, from studies on the partial heat inactivation,
the pH dependence, and the ammonium sulfate fractionation, tend to support
the view that a single enzyme is responsible for both the CDNAase activity
and the LNAase activity.
To obtain further evidence either in support or in opposition to
this view we tested the effect of a number of agents on the two known
activities of S(50-70)D.

These results are summarized in Table XI.

0.1 mM

oxytocin inhibited LNAase activity twice as much as it did CDNAase activity
(-60% compared to -30%).

If oxytocin is acting as a competitive inhibitor,

we may conclude that it is a better competitor of LNA than of CDNA (the
initial concentration of LNA was twice that of CDNA).

This is consistent

with the view that a single enzyme acts on CDNA and on LNA but that the K
m
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of CDNA is less than the K of LNA; in other words, the enzyme binds CDNA
m
better than LNA. On the other hand, two enzymes could be present, both of
which are inhibited by oxytocin.

TABLE XI
The Effect of Various Agents on the CDNAase
and LNAase Activities on S(50-70)D
The incubation mixtures contained CDNAase in excess of saturation and LNA
at 10 ° M, except for the experiments with oxytocin and with MgS04 in
which the concentration of LNA was 1.25 x 10""4 M. MnCl2 was pre-incubated
with S(50-70)D for 75 minutes at 30° C. The other agents were added with
substrate at the start of the incubation. Incubations were at 30° C for
30 minutes.

Agent

Per Cent Increase or Decrease of Activity
CDNAase

LNAase

0.1 mM oxytocin

-30

-60

1 mM L-cysteine

+60

0

5 mM versene

-10

-35

1 mM L-leucine

0

+ 15

2 mM MgS0 4

0

+20

1 mM MnCl2

-5

-25

1 mM HgCl 2

-100

-100

Another large difference in the effect on the two activities was
obtained with cysteine.

1 mM cysteine enhanced CDNAase activity by 60%,

but did not effect LNAase activity.

On the basis of the one enzyme view,

this would have to be explained as an effect of cysteine on the substrate,
CDNA, perhaps through the formation of the mixed disulfide, L-cystinemono-beta-naphthylamide, or through reduction to form L-cysteine-betanaphthylamide.

These compounds might be more easily attacked than CDNA.
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5 mM versene appeared to have a greater inhibitory effect, and 2 mM
MgSO

a greater stimulatory effect, on LNAase activity than on CDNAase

activity.

Below, in the Discussion, we will compare these results with

those obtained by others with leucine aminopeptidase and with pregnancy
serum oxytocinase.

In the meantime our working hypothesis is that an en-

zyme exists in the toad bladder epithelium which inactivates oxytocin, and
which acts like an aminopeptidase both in its action on oxytocin and on
synthetic substrates.

The question we ask now is what possible physio-

logical significance could such an enzyme have.
to this question in the next section.

We shall address ourselves
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D

-

Interactions of Oxytocin with the Intact Bladder

Methods
The technique of measuring the change in permeability of the bladder
in response to oxytocin has been described in Methods, A.

A few modifi-

cations of the previously described technique were made in the work in this
section.

The inside of the bladder (i.e., the mucosal solution) was now

filled with 5 ml of water rather than 3 ml.

The outside (serosal) solution

was 25 ml as before, but consisted of Ringer's solution containing 5 mM
glucose and 5 mM sodium pyruvate (pH 7.7); the glucose and sodium pyruvate
being added shortly before use.

In this section we will call this latter

solution, simply, Ringer's.
The protocol for these experiments was as follows: Five or six
half-bladders, each from a different toad, were used in each experiment.
The number of assay tubes which were set up was two, three or four times
the number of half-bladders.

If six half-bladders were used, then there

might be three sets of six tubes each.
tubes 7-12, and tubes 13-18.

We will call these sets, tubes 1-6,

Each tube was filled with 25 ml Ringer's and

air bubbled through as previously described (Methods, A ) . The six halfbladders were mounted on the inserts, filled with 5 ml of water, and placed
in tubes 1-6.

The half-bladders were then consecutively weighed exactly 2

minutes apart; at 0 min the first, at 2 min the second, etc.

After a 20 min

interval each half-bladder was weighed again, the first at 20 min, the
second at 22 min, etc.

The difference between the first and the second

weighing corresponded to the loss of water from the inside of the halfbladder during this 20 minute interval.

The half-bladders were weighed

again after another 20 minute interval.

The difference between the second

weighing and the third weighing was equal to the loss of water during the
second 20 minute interval.
intervals.

All experiments began with two such 20 minute

Together, they constituted a 40 minute control period during

which the base line, the rate of loss of water in the absence of hormone,
was determined.

This rate was always low compared to the rate in the

presence of hormone.

Shortly before the third, and last, weighing of the

control period, an equal dose of oxytocin was added to each of the tubes
7-12; that is, oxytocin was added to tube 7 one minute before the last
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weighing of the half-bladder in tube 1, and to tube 8 one minute before
the last weighing of the half-bladder in tube 2, etc.

The last control

weighing of each half-bladder was actually at 19 min 30 sec, so that
exactly on the minute each half-bladder was transferred to a tube containing oxytocin, from tube 1 to the balance to tube 7, from tube 2 to the
balance to tube 8, etc.

The last weighing of the control period was also

the first weighing of the first test period.

During the test periods the

weighing procedure was as follows: After a 19 minute interval, each of
the half-bladders (always 2 minutes apart) were weighed and the loss during
the past interval quickly calculated.

The amount of water lost was then

added back to the mucosal solution by the following method.

A 2 ml syringe

with a short length of polyethylene tubing attached was inserted into the
top of the hollow glass insert and a volume of water approximately equivalent to the amount lost was added.

During this operation the half-

bladder was in its serosal solution.

Then the half-bladder was re-weighed

and again returned to its assay tube.

The entire operation applied to each

half-bladder was then to remove from tube, weigh, return to tube, add back
loss, remove from tube, re-weigh, and return to tube.

This process took

1 minute, so that the first half-bladder was first weighed at 19 minutes
and was finally returned at 20 minutes, the second half-bladder was first
weighed at 21 minutes and was finally returned at 22 minutes, etc. Hence,
during the test periods the actual length of the interval during which the
loss was measured was 19 minutes, or in some experiments 9 minutes.

In

the latter experiments, at most five half-bladders could be accomodated,
these being weighed at 9,11,13,15 and 17 min, and next at 19,21,23,25, and
27 min, etc.
Whether the intervals between weighings were 10 minutes or 20 minutes
(intervals of actual measured loss of 9 minutes or 19 minutes) the test
period ran 60 to 120 minutes.

In some experiments, in particular those in

which the time course of the rate of loss was determined, the experiment
concluded at the end of the test period.

In many others, at the end of the

test period, the half-bladders were transferred from tubes 7-12 back to
tubes 1-6.

Weighing continued in tubes 1-6 at 20 minute intervals.

By

the second 20 minute interval the rate of loss was back to the control
values, and the half-bladders were then transferred to a third set of tubes
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containing hormone for a second test period.

The 40 minute period between

two test periods is called a recovery period.

An experiment then could run

as follows: a 40 minute control period in tubes 1-6, an 80 minute test
period in tubes 7-12 (containing oxytocin), a 40 minute recovery period in
tubes 1-6, and a 60 minute second test period in tubes 13-18 (containing
oxytocin) .
The response of a half-bladder during a test period is defined as
the total loss of water of that half-bladder during the first 60 minutes of
the period.

The actually measured loss was for 19 minute intervals.

These

values were multiplied by 20/19 to correct to 20 minute intervals, and the
losses of the first three intervals were added.

The response of the first

test period is called L , and of the second test period, L , etc.
1

To com-

a

pare two test periods, L -L

was calculated for each half-bladder.

The

mean difference, L,-L„ + S , the standard deviation of the mean, was cal1 2 — m
culated. The significance of the mean difference was determined by the
t-test. The ratio of the mean hormone concentrations present in the serosal
solutions during the first and during the second test periods was estimated
from L -L by the following procedure. A standard log concentration— _>
response curve was determined (Figure 26). The regression coefficients of
the linear region of this curve were determined. In particular, the slope,
b, was determined.

Since the response, L, is linearly related to the log

concentration of hormone, log C,
C
L

L

l" 2

= b(log C

l "

log C >

2

= b log

C~ '1° r

The error in log •— is due to the error in L -L
C
2

C
l0g

,C~

=

1

L -L
1 2

and to that in b.

The

standard deviation of b, however, was only 8% of b and made a negligible
contribution to the standard deviation of log —-• (less than 10% of total
standard deviation).

— \
Therefore, the standard deviation of log —

was

sn
taken as •-—
b

(Sm is the standard deviation of the mean of L, -L„). —
m
1 2
C

was
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estimated by taking the anti-logarithm of log —— , and bounds were estiC
2
C
S
C
S
i
mated by taking the an ti-logarithm of log —- + -_ and of log —
- •-— .
2
2
The osmolal concentration of solutions was determined in a Fiske
Osmometer with a KC1 standard.

Results
In the previous sections we were concerned with the characterization
of certain extracts of the toad bladder which inactivate oxytocin and
split N-terminal peptide bonds.

We presented evidence that there is at

least one enzyme present which splits an

N-terminal half-cystinyl peptide

bond in the substrate, CDNA, and might inactivate oxytocin by splitting a
similar bond.

In both of these cases, this enzyme would be acting as a

cystine-aminopeptidase.

The fact that N-terminal cystinyl bonds are not

readily split by the widespread enzyme, leucine aminopeptidase (see the
Discussion) encouraged the view that the oxytocin inactivating potency of
the bladder extracts could have some specific function with regard to the
action of the neurohypophyseal hormones on the intact toad bladder.

The

simplest idea would be that this enzyme limited the duration of the effect
of the hormone through inactivation.

It was such an effect then for which

we first looked; that is, we observed the time course of the response of
the bladder to a single dose of hormone.
The experiments were performed as described in the Methods.

There

was a 40 minute control period in tubes 1-5; then a 110 minute test period
in tubes 6-10 containing oxytocin.
10 minutes.

The intervals in the test period were

Two experiments, containing 5 half-bladders each, were per-

formed at each hormone concentration.
during each interval was calculated.

The mean rate of loss in mg per min
The results are shown in Figure 25.

Characteristically, the maximum rate of loss was reached 10 to 20 minutes
after the addition of hormone.

Thereafter, the rate of loss declined, and

was about 50% maximum 80 to 90 minutes later.

At the lowest concentration

tested, 2.5 muM, the effect was barely perceptible; and at the highest
concentration, 80 m|_M, the rate of loss was only slightly greater than that
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Figure 25.

The time course of the effect of various concentrations of

oxytocin on the water permeability of the toad bladder.
The experimental values are given as the mean rate of loss in mg
per min + the standard deviation of the mean.

The weighing intervals

are indicated by the length of the horizontal sections.

The half-bladders

were placed in Ringer's containing oxytocin at t = 0 min.

The mean rate

of loss during the 40 min control period is given at t < 0 min.
bladders were used at each concentration.

10 half-

(The curves were calculated

from a theoretical model of hormone action).

1

1

120

45

at the next lower concentration, 40 mp.M (the curves in Figure 25 and Figure
26 have been calculated from a model of hormone action; cf., below).

There

is no question that the effect of a single dose of oxytocin decreases with
time.
The dependence on hormone concentration of the mean response, defined as the mean total loss during the first 60 minutes, is shown in
Figure 26.

Hormone concentration has been plotted on a log scale.

The

slope of the regression line fitted to the four central points (5,10,20,
and 40 rmiM) was calculated to be 2120 + 170 mg per hour per ten times increase in hormone concentration (i.e., per log unit).
m^M oxytocin was 80 + 30 mg per hr.

The response at 2.5

This is not significantly different

than the control response which was about 60 mg per hr.

Also, the response

at 80 mp.M oxytocin, 2245 + 120 mg per hr, is not significantly different
than the response at 40 mjiM, 2230 + 130 mg per hr.
Now that we see that the effect of a dose of oxytocin declines with
time, we must try to answer why.

The first question we must ask is whether

irreversible, degenerative changes are occurring in the isolated bladder,
and whether these changes lead to the decrease in effect.
question the following experiment was performed:

To answer this

There was a 40 minute

control period in tubes 1-6, then an 80 minute test period in tubes 7-12
containing 20 muM oxytocin, then a 40 minute recovery period in tubes 1-6,
and then a 60 minute test period in tubes 13-18 containing 20 muM oxytocin.
In other words, after recovery from the first dose, the half-bladders have
been exposed to an equal second dose.

The time course of the effect of

these changes on the rate of water loss is shown in Figure 27.

The effect

of the first dose of oxytocin was clearly declining by the last 20 minute
interval of the first test period.

When the half-bladders were removed

from Ringer's containing oxytocin and placed in Ringer's not containing
oxytocin (at the second arrow), the rate of loss decreased in about 20
minutes to the level of the control.

Clearly the effect of oxytocin con-

tinues only so long as the hormone is present in the serosal solution.
Following the recovery period, the half-bladders responded fully to a
second equal dose of oxytocin in new Ringer's.

The actual mean difference

in response and calculated ratio of hormone concentrations is given in
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Figure 26. The total loss of water during the first 60 minutes of
activity versus the log concentration of oxytocin.

The theoretical

curve is a plot of the integral from 0 to 60 min of the curves in
Figure 25.
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Figure 27.

The response of the half-bladders to a second dose

of oxytocin following a recovery period.
The mean rate of loss of water in mg per min is plotted
against minutes.

The 40 min control was in tubes 1-6.

The half-

bladders were transferred (at the first arrow) to tubes 7-12 containing 20 muM oxytocin.

At 120 min (second arrow) the half-

bladders were transferred back to tubes 1-6, and at 160 min (third
arrow) to tubes 13-18 containing 20 muM oxytocin.
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Table XII, experiment a.

The difference in response was not significant.

We can rule out then that the decline in the effect of oxytocin is due to
irreversible changes in the isolated bladder.
We might then ask whether the decline is due to the decrease in
osmotic gradient caused by the flow of water from the mucosal solution to
the serosal solution.

This decrease in osmotic gradient can be calculated.

From Figure 26, we can see that about 1700 mg, or 1.7 ml, of water enters
the serosal solution in one hour at an oxytocin concentration of 20 muM.
The initial volume of the serosal solution was 25 ml.

Therefore the con-

centration of solutes has decreased by a factor of 25/26.7 = 0.94, or by
6%.

The concentration of solute in the Ringer's was 224 mOsm.

The con-

centration of solute in the mucosal solution after 60 min was 1 0 + 5 mOsm
(most of this solute must have been present from the start in a residual
amount of Ringer's in which the bladders were originally washed).

There-

fore, the decrease in the osmotic gradient was not greater than 10% in the
first hour of activity.

Moreover, as the rate of water loss declined,

rate of' decrease in osmotic gradient would decline also.
experiment settled this question.

the

The following

The half-bladders were first in tubes

1-6 for 40 minutes, then in tubes 7-12 containing 20 muM oxytocin for 80
minutes, then in tubes 1-6 for 40 minutes, then for 60 minutes in tubes
13-18 containing 20 muM oxytocin and to which were added the amount of water
lost by each half-bladder during the first 80 minute test period.

The

amount lost by the first half-bladder was added to tube 13, the amount lost
by the second to tube 14, etc.

Therefore, if dilution of the serosal

solution were an important factor in the decline of the oxytocin effect,
the second response should be less than the first.

In fact the second

response was slightly, though not significantly, greater than the first
(Table XII, experiment b).

Therefore the dilution of the serosal solution

was not an important factor in the decline of the effect of oxytocin.
Another possible explanation for the decline is that the exogenous
substrates, glucose and pyruvate, were being depleted, and that in some
way the maintenance of high permeability is coupled to the metabolism of
these substrates.

We tested this with the following experiment.

The half-

bladders were 40 min in tubes 1-6, 60 min in tubes 7-12 containing 20 muM
oxytocin, 40 min in tubes 1-6, and finally 60 min in tubes 13-18 in which

TABLE XII
Resume of the Inactivation of Oxytocin by the Intact Bladder

Experiment

Mean Difference in Response
between the First and Second
Test Periods

Calculated Ratio
of Concentrations

mg/hr

a

-68 +

52

(P > 0

2)

0.93 + 0.05

b

-46 +

72

(P > 0 . 5 )

0.95 + 0.08

c

-69 +

91

(P>0.4)

0.93 + 0.09

d

723 +

54

(P < 0 . 0 0 1 )

2.2

e

452 + 106

(P < 0 . 0 1 )

1.65 + 0.2

(P>0.4)

1.1

+ 0.1

f

70 +

94

+ 0.2

g

372 + 132

(P<0.05)

1.5

+ 0.2

h

737 + 146

(P < 0 . 0 1 )

2.2

+ 0.4

i

651 + 140

(P <

2.0

+ 0.3

J

-364 + 109

0.01)

(P < 0 . 0 5 )

0.67 + 0.08

a.

40 min in tubes 1-6; 80 min in tubes 7-12 + 20 muM oxytocin (L^); 40
min in tubes 1-6; 60 min in tubes 13-18 + 20 mpM oxytocin (L2).

b.

40 min in tubes 1-6; 80 min in tubes 7-12 + 20 muM oxytocin (Li); 40
min in tubes 1-6; 60 min in tubes 13-18 + 20 muM oxytocin + the amount
of water lost by each half-bladder in the first 80 min test period (L2)•

c.

40 min in tubes 1-6; 60 min in tubes 7-12 + 20 muM oxytocin (Li); 40
min in tubes 1-6; 60 min in tubes 13-18 in Ringer's minus glucose and
pyruvate + 20 rmiM oxytocin (L2).

d.

40 min in tubes 1-6; 80 min in tubes 7-12 + 20 muM oxytocin (Li); 40
min in tubes 1-6; 60 min in tubes 7-12 (L2).

e.

40 min in tubes 1-6; 80 min in tubes 7-12 + 20 muM oxytocin (L]^) ; 40
min in tubes 1-6; 60 min in tubes 7-12 + 10 muM oxytocin (L2).

f.

40 min in tubes 1-6; 80 min in tubes 7-12 + 20 m^M oxytocin (Li); 40
min in tubes 1-6; 60 min in tubes 7-12 + 20 muM oxytocin (L2).

g.

40 min in tubes 1-6; 100 min in tubes 7-12 + 10 muM oxytocin (Li); 40
min in tubes 1-6; 60 min in tubes 7-12 + 10 muM oxytocin (L2).

h.

60 min in tubes 1-6; oxytocin (20 muM) added to tubes 1-6 just after
half bladders transferred out; 60 min in tubes 7-12 + 20 muM oxytocin
(Li); 40 min in tubes 13-18; 60 min in tubes 1-6 (oxytocin having been
in tubes 1-6 for 100 min) (L 2 ).

60 min in tubes 1-6; 60 min in tubes 7-12 + 20 mjiM oxytocin (L^) ; 40
min in tubes 13-18; 60 min in tubes 1-6 + 20 IWAM oxytocin (L 2 ).
60 min in tubes 1-6; 60 min in tubes 7-12; 60 min in tubes 1-6 +
20 m,_M oxytocin (L^); 40 min in tubes 13-18; 60 min in tubes 7-12 +
20 muM oxytocin (L 2 ).
The experiments
condensed form.
ferred from one
of water during
loss during the

discussed in the text have been described here in a
In all experiments the six half-bladders are transset of serosal solutions to another. L^ is the loss
the first hr of the first test period, and L 2 is the
first hr of the second test period.

L -L
1 2
2120
10

(see Methods).
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Ringer's containing no glucose and pyruvate was substituted for the usual
Ringer's, and containing 20 muM oxytocin.

In other words, the second

response was in Ringer's minus glucose and pyruvate.

Again the two res-

ponses were not significantly different (Table XII, experiment c).

We

might also mention at this point that the pH of the serosal solutions
bathing the half-bladders did not change detectably after 60 min in the
presence of 20 mjiM oxytocin.
It appears then that we are left with two alternatives: either
oxytocin is being gradually inactivated or a reversible change in the
bladder epithelium such as the depletion of some critical endogenous substrate is occurring.
both could occur.
experiment.

These alternatives are not mutually exclusive, and

We tested for inactivation of oxytocin by the following

The half-bladders were 40 min in tubes 1-6, 80 min in tubes

7-12 containing 20 muM oxytocin, 40 min in tubes 1-6, and then 60 min back
in tubes 7-12.

If the oxytocin in tubes 7-12 had not been appreciably in-

activated during the first test period, the response in the second test
period with the half-bladders being placed again in tubes 7-12 should equal
the response in the first test period, as would be predicted by the results
of experiment a (Table XII).

In fact, the second response was significantly

less than the first (Table XII, experiment d). The calculated ratio of
oxytocin concentrations was 2.2.

Hence, since the initial hormone concen-

tration of the first test period was 20 muM, the initial hormone concentration of the second test period, also the final hormone concentration of
the first test period, was apparently 9.1 mjaM.

It appeared then that during

the 80 minute first test period about 50% of the oxytocin had been inactivated.

During the same time the mean rate of loss had appreciably declined

from 27 mg per min during the first 20 minute interval to 16 mg per min
during the fourth, and last, 20 minute interval.

Here it seemed we had

found the principal factor causing the decline in the effect of a dose of
oxytocin.
To verify that the lower second response in the above experiment was
due simply to inactivation of the oxytocin, we performed the same experiment,
but before the second test period we added to tubes 7-12 the amount of
oxytocin that we estimated had been inactivated in the first test period,
which in the previous experiment had been 50% of the first dose.

Therefore,
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we added half of the original dose, which should have brought the concentration of oxytocin in the serosal solutions up to the initial value of
20 muM.

However the results did not support this contention.

The second

response was considerably less than the first (Table XII, experiment e ) .
The apparent ratio of concentrations was 1.65.

Since the initial concen-

tration of oxytocin in the first test period was 20 muM, that in the second
seemed to be 12 imaM.

But 10 mp.M had been added at the start of the second

test period; therefore, the final oxytocin concentration in the first test
period apparently was about 2 muM.

During the 80 minute first test period

the mean rate of loss of water declined from 29 mg per min during the first
20 minute interval to 22 mg per min during the fourth 20 minute interval.
A greater decline in effect than this would be expected if the oxytocin
concentration had actually fallen to 2 muM which is below the lowest concentration in the standard log dose-response curve (Figure 26).
The same experiment was repeated, but instead of the second dose
being equal to half the first dose, an equal dose was added the second
time.

Therefore, the concentration of oxytocin in tubes 7-12 was raised

by 20 muM.

Again, if 50% of the original dose of oxytocin remained, then

the initial concentration of oxytocin in the second test period would have
been about 30 muM.

The first and second responses, however, were not

significantly different (Table XII, experiment f).
response was actually slightly less than the first.

If anything, the second
Thus it appeared that

the initial oxytocin concentration in the second test period was just 20 muM.
In other words, it appeared that no appreciable amount of oxytocin remained
at the end of the first test period.

During this test period the mean rate

of loss had declined from 19 mg per min to 13 mg per min, the latter rate
still being quite substantial compared with the control rate of 1 mg per
min.
The above experiment was repeated except that the first test period
was extended to 100 minutes (instead of 80 minutes) and the initial concentration of oxytocin reduced to 10 muM.
7-12 was equal to the first.

Again the second dose to tubes

In this case the second response was actually

significantly less than the first (Table XII, experiment g ) .
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In summary then, .when the half-bladders were returned for the second
test period to the same serosal solutions in which they had been during the
first test period, it appeared that about 50% of the initial dose of oxytocin had been inactivated.

When this amount of oxytocin was added to the

serosal solutions of the first test period prior to the second test period,
it appeared, subtracting the amount added, that about 90% of the original
dose had been inactivated.

Finally, when a second dose equal to the first

was added to the serosal solutions of the first test period prior to the
second test period, it appeared that not only was there no oxytocin left
from the first period but that the second equal dose had even less effect
than the first.

But we have already seen that an equal second dose of

oxytocin in fresh Ringer's gave a response equal to that produced by the
first dose (Table XII, experiment a, b and c).

The only possible conclusion

is that the second dose of hormone added to the same Ringer's as the first
is not having an effect equal to the first, in fact less of an effect,
because of some change in the serosal solutions.

We have already ruled out

the depletion of glucose or of pyruvate as a cause (Table XII, experiment e ) ,
and the pH of the serosal solutions does not change (see above).

Another

possibility, however, is that either an oxytocin inactivating enzyme or an
oxytocin inhibitor is accumulating in the serosal solutions.

We proceeded

to test these possibilities.
The first experiment we tried was as follows:
in tubes 1-6 for 60 min

The half-bladders were

and oxytocin was added to each tube (to 20 muM)

just after each half-bladder was removed, then the half-bladders were 60
minutes in tubes 7-12 containing 20 muM oxytocin, then 40 minutes in tubes
13-18 (recovery), and then 60 minutes in tubes 1-6.

In other words the

responses to equal doses of oxytocin were compared; one dose had been added
to tubes 7-12 containing fresh Ringer's just before the half-bladders were
placed in them, the other dose had been added to tubes 1-6 containing
Ringer's in which the half-bladders had remained previous to the addition
for 60 minutes, and the oxytocin remained in these tubes for 100 minutes
before the half-bladders were placed in them again for the second test
period.

If an oxytocin inactivating enzyme were leaking out of the bladder

into the serosal solution, incubation of oxytocin with that solution for
100 minutes would be expected to lead to considerable inactivation and hence
to a decrease in response.

In fact this was found to be the case.

The

second response was considerably less that the first (Table XII, experiment h ) .

50

As a control for the above experiment, the identical experiment was
done except that the oxytocin was added to the serosal solutions (tubes 1-6)
in which the half-bladders had remained for 60 minutes just 30 seconds
(instead of 100 minutes) before the half-bladders were placed in these
tubes for the second time.

If the lower second response in the previous

experiment had been due to enzymatic inactivation of oxytocin, surely a
100 minute incubation would cause greater inactivation than a 30 second
incubation.

In fact, however, the second response was again considerably

lower than the first (Table XII, experiment i ) ; moreover, the mean differences of response in this experiment and in the previous experiment
(experiment h) were not significantly different (P>0.3).

This result

clearly supports the view that an inhibitor of the action of oxytocin, not
an inactivating enzyme, accumulates in the solution bathing the serosal
side of the bladder.

We must include the possibility that this inhibitor

may be a substance which binds oxytocin, for the accumulation in the serosal
solution of a binding substance would explain the results as well as would
the accumulation of an inhibitor in the usual sense.
In one further experiment we found that the inhibitory factor could
be washed out of the bladder.

In this experiment the half-bladders were

first in tubes 1-6 for 60 minutes, then in tubes 7-12 for 60 minutes, then
back in tubes 1-6 plus 20 muM oxytocin for 60 minutes, then for 40 minutes
recovery in tubes 13-18, and finally for 60 minutes in tubes 7-12 plus
20 muM oxytocin.

In essence we were comparing the amount of inhibiting

factor released by the bladders in the first and in the second hour of
their remaining in Ringer's.

The first response was significantly less

than the second (Table XII, experiment j).

In other words, more inhibiting

factor accumulated during the first hour of soaking than during the second.
In fact the second response corresponded to an oxytocin concentration 1.5
times the first.

In both cases however, the second as well as the first,

the rate of loss declined over the 60 minute test period.

In the first

the rate decreased from 34 mg per min to 28 mg per min, and in the second
from 40 mg per min to 28 mg per min.

Hence, if the release of this in-

hibiting factor into the serosal solution is the cause of the decrease in
the rate of loss of water in response to a dose of oxytocin, either there
is more of this factor in the bladder than can be washed away in 60 minutes,
or more of it is produced in the presence of oxytocin.
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In summary, we have first demonstrated that the rate of loss of
water in response to a single dose of oxytocin rises to a maximum in 10 to
20 minutes and then decreases to 50% of the maximum in 80 to 90 minutes
more.

We have inquired into the causes of this decrease in rate and found

that it could be accounted for by changes in the hormone activity of the
serosal solutions bathing the bladders.

It was found that an inhibiting

factor was released into the serosal solutions in which half-bladders had
been for 60 minutes.

This inhibitory factor decreased the subsequent

activity of a dose of oxytocin about 50% (Table XII, experiment i). If an
approximately equal amount of inhibiting factor accumulated in the serosal
solutions in experiments e, f, and g, in which additional doses of oxytocin
were added to the serosal solutions, the results of these experiments would
be explicable.

For instance, in experiment f we added an additional dose

of oxytocin equal to the first, but the subsequent response was just equal
to the first.

If the effective concentration of oxytocin was decreased

about 50% by the inhibiting factor accumulated during the first test period
such a result would be reasonable.

Moreover, we found that the inhibiting

factor could be v/ashed out of the bladder, at least in the absence of
oxytocin.

It should be noted, however, that in all experiments the half-

bladders were first soaked for at least 40 minutes (the control period) in
different Ringer's than that In which they subsequently responded to oxytocin.

In all cases the rate of loss still declined during the test period.

One possible explanation for this is that the inhibiting factor is formed
in response to oxytocin.

In that case, the inhibiting factor washed off

the bladders before any exogenous oxytocin had been added to them (experiment h, i, and j) would have to be due to inhibiting factor formed in
response to endogenous hormone, probably before the bladders were excised.
In the next section we will develop a model of hormone action based on the
hypothesis that an inhibiting factor is formed in response to oxytocin, but
with the specification that the inhibiting factor is an inactivated product
of the hormone itself.
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A Model for the Control of Hormone Action
In the previous section we found that a likely explanation for the

decrease in the effect of a dose of oxytocin is that an inhibitor of the
hormone is formed in the bladder, and that the formation of this inhibitor
is induced by the hormone itself.
hypothesis.

We have constructed a model based on this

In particular, we assume in this model that the hormone acts

by combining reversibly with receptor sites in the bladder epithelium, that
the hormone is inactivated in the epithelium by an inactivating enzyme, and
that the product of this inactivation can compete with the hormone for the
receptor sites.

In other words, we hypothesize that the inhibitor that

collected in the serosal solutions in the experiments of the previous section
was a product of hormone inactivation.

The model is schematically repre-

sented in Figure 28.
The assumptions we make and their mathematical representations are
as follows.

We assume that the hormone diffuses from the serosal solution

to the receptor sites, which presumably are in the epithelial cells.
Furthermore, the permeability of the epithelial cells to the hormone is not
constant but is directly proportional to the concentration of hormone already in the cell.

The hormone, we know, has a profound effect on the

transport of water and salt.
effects its own transport.

We are here postulating that the hormone also

The expression then for the rate of increase

of hormone concentration inside the cell is

D

d(h.:
dt

a(h.)((h )-(h.))
I
o
i

-Jdif
where (h ) is the hormone concentration outside, (h ) is the hormone cono
i
centration inside, and a is a constant. This is a diffusion equation in
which the permeability is given by a(h.). This postulate on the hormone
permeability has been made so that the theoretical water permeability will
increase at low hormone concentrations with the second power of the hormone
concentration; that is, so that the predicted dose-response curve will be
concave upwards at low hormone concentrations (cf. Figure 26) .
We assume next that the hormone combines reversibly with the receptor sites, and that this reaction is at equilibrium.

Therefore,

Mucosal
membrane

Serosal
membrane
Epithelial cell

Hn<"
-^H20

H 0 = hormone outside
Hj = hormone inside
I = inactivated hormone
S = receptor site

<

- = chemical or diffusional reaction
- = increases rate

Figure 28. A model of the interaction of hormone with the
bladder epithelial cells.
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0^) (s)
2)

h

(hs)

where (s) is the concentration of receptor sites, and (hs) is the concentration of the hormone-receptor complex, and KL is the equilibrium constant
We assume that the hormone is inactivated, and that the rate of inactivation is first order (which is not unreasonable considering the low
concentrations involved).

Therefore,
d(h.)

3)

= -bO^)

dt
Jenz

where b is a constant.

Furthermore, the rate of change of (i) , the con-

centration of the product of the inactivation is given by

4)

d(h.)

d(i)
dt

dt

=

b(h A )

enz

We are neglecting changes in (i) due to diffusion out of the cell and to
further enzymatic degradation.
We assume further that the product of the inactivation combines reversibly with the receptor, and that this reaction is at equilibrium.
Therefore,
(i) (s)
-> K.
(is)

5)

where (is) is the inactive product-receptor complex, and K

is the equili-

brium constant.
We assume that the permeability of the bladder, w, in mg water lost
per half-bladder per rain, is directly proportional to the concentration of
the hormone-receptor complex.

6)
where 1 is a constant.

Therefore,
w=l'(hs)

Equations (l)-(5) must now be solved for (hs) as a

function of t., and then (6) will yield w as a function of t.

In solving

equations (1) and (3), we make one more simplifying assumption and that is
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that the outside concentration of hormone, (h ) , remains constant in time.
o
We are assuming essentially that the total amount of hormone inactivated
by a half-bladder in 2 hours is small compared to the total amount of hormone in the serosal bath.

The validity of this approximation will depend

on the rate of inactivation, b, and on the outside hormone concentration,
(nQ)•

Without this assumption, however, the equations could not be solved

in closed form.
Let us define the total concentration of receptor sites as (s )
Then,

7)

(s t )

ss

(s) + (hs) + (is)

Combining (7) with (2) and (5), with the elimination of (s) and (is), we
get
K

8)

(hs) =

I< s t> ( h i>
I^K. + 1^(1) + K j O ^ )

Adding (1) and (3), we find the total rate of change of (h )

9)

~"dt

<v

a(h.)((h )-(h.)) - b(h.)
i
o
1
i

to get,

and we can integrate

10)

«

(a(h )-b)(h')
o
i
(a(h )-b-a(h'))e" ( a ( h o ) " b ) t
o
i

where (h') is the initial value of (h ) .

+ a(h')
i

(h') clearly must be greater

than zero; otherwise the initial hormone permeability would be zero.

Com-

bining (4) and (10) we can solve for i:

11)

<*>-

a"

(h!)
log - ~ y

+ (a(hQ)-b)t

where the initial value of (i) is taken equal to zero.
combining (6), (8), (10), and (11), we have

Finally, then,
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L(ht)
w

=

K
K

H

(a(ho)-b)t - log

H

- ^ + (hj)

12)
(a(h )-b)(h!)

<V =

O

1

(a(h )-b-a(h.'))e"(a(ho)"b)t + a(h.')
o
1
1

where L = 1 (s + ). We now have an expression for w in terms of the independent variables, Jt and (h ), and of six constants. We must try to evaluate these constants and thereby fit equations (12) to the experimental
data represented in Figure 25.
From (12) we derive the following expressions.

At

t = 0, (h ) =

(h^), and

L(hp
13)

w =
o

wt=0

As can be seen in Figure 25, w

KJJ

+ (h^)

= 1 mg per min.

By differentiating (10),

d(h±)
we find the condition

~~dt

tagQ

> 0

if and only if

(h Q )>- + (h^) ;

that is, for (h ) <C — + (h.'), there is no increase in inside hormone
o — a
i
concentration, and hence no effect. Thus we can define a cut-off concentration, (h ), at or below which the hormone has no effect, and
c
14)

(h ) = 7 +
c
a

(h')
I

We cannot accurately determine (h ) from our data but we can take it to
c
be a reasonable value consistent with our data. We observed that
-9
2.5 x 10
M oxytocin had a barely
perceptible effect. We then can
-9
reasonably take (h ) = 2 x 10
M.
c
Quantities that can be approximately determined from the data are
the maximum values of w, w , and the times of the maxima, t
—
max
max
Relationships involving these two quantities are derived by setting dw
dt

(h

5)

i}

K

(a(h )-b)t

, .. . .

TTTTT e

o

max

=

(a(h )-b-a(h'))
o
i

and
16)

K„
H

l

(

1 I"

-~ + -

b

) -b)tmax- l0g

(a(h

a

Vt

Thi)

o
i—

(L-w
)(a(h )-b)(a(h )-b-a(h.'))e'(a(ho)"b)tmax
max
o
o
l
w
b (a(ho)-b-a(h.'))e"(a(ho)"b)tmax + a(h')
max

When t is large, equation (10) reduces to (h.) = (h )
—
I
o
bining this with equation (12), we find
K

17)

H

1 -

log
K

o

a-

ia

o
a
+ 1 + ~
(h^)
K
I

, and coma

bt

Equation (17) implies that when t_ is large enough (in practice, when
t ;> t ), the decline in the permeability, w, is hyperbolic. At every
~~"

ni3x

~~~

hormone concentration, (h ), the plot of — versus t for t > t should be
o
w
—
max
linear. The slope, m, should be equal to
18)

m =

y
LK.

The intercept, g, of the line depends on (h ) , and is given by
—
o

h

19)

o

<h
b

1
a

- K^a

l0g

o>- !

-TEJT

Now using these relationships, (13) through (19), we can determine
the six constants. The procedure used was as follows. We calculated from
1 —8
the experimental data — for t > t
and for (h ) from 1 to 8 x 10
M.
r
w
— ' max
o
We then calculated the least-squares line for each (h ). The slopes were
very nearly the same, as predicted, and m was taken as the mean slope:

20)

m

=

__
LK.

=

2.5 + 0.4 x 10

-4
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Next, equation (15) was used.

This equation could be considerably

simplified by assuming that the second term on the right was small compared with the first term, an assumption which was later verified, and by
neglecting b and a(hp compared to a(hQ) . We were left with the approxi(h.') a(h )t K
i
e
m94.inn
mation ••
•
av,n J

o

max
-

ni\
J l

max

=

a(hQ)

.
±0g

I
_
,
-__ • Rearranging and solving for t
gave
b
max
1
I

K

,

Ta(h^>
I
O

b(h.')

Equation (13), upon rearrangement, yielded (h.') = . But L is an
o
upper bound for w, and is therefore >60, while w , the initial value of
w, is 1. Therefore,
w K
22) (h.*) =» -^

to a close approximation.

Combining equations (20), (21), and (22), we

found
1

a(h }

o

23)

t
_»
log
max
a(h )
m
o
a function of (h ), and of two constants, m,
o
—
evaluated, and a. We then tried different values
until we found a value which gave values of t
max
with the experimental data. The value accepted for

which determines t as
max
which we have already
of a in equation (23)
—
reasonably consistent
+7
a was 3 x 10 . Using this value of a, the error in the approximation of
equation (15) by equation (23) was estimated and found to be small.
An approximate relationship involving w was derived by combining

equations (16), (18), and (23), and by again neglecting b and a(hp com-

pared to a(h):
o
24)

1
w
max

1
o

i • <hi>

+

1
L
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A plot of —

(experimental) versus -.v- y should yield a straight line.
max
o
The slope of this line should give an estimate of (hj), since both m and
a are known, and the intercept should determine L. In drawing the line,
the points corresponding to the higher concentrations of hormone (20,40,
80 muM) were weighted more heavily than the points corresponding to the
lower concentrations (5 and 10 m|_M), because the approximations involved
in the derivation of (24) became increasingly inaccurate at the lower
values of (h ) . From this line we determined that L = 91 and that
o
(hj) s* 2.9 x 10 °.
i

From equation (13), and the above values of L and (h!), K_ was
evaluated, and it was found that L = 2.6 x 10 . Substituting the values
found for a and for (h!) in equation (14), and taking (h ) = 2 x 10 M,
1
C
-2
-8
we found that b = 5.1 x 10 . Equation (20) then yielded, K = 5.7 x 10
Finally we tested our approximations by substituting the estimated values
of the constants in the still unused equation (19), and we found that the
calculated values of the intercepts agreed well with those of the leastsquares lines.
In summary, the constants were estimated as follows:
L

=s 91 mgoliter.min . mole

a
b

a
»

"H
K

7
-1
-1
3 x 10 liter#mole
min
5.1 x 10" 2 min" 1

-8
-1
2.6 x 10
mole«liter
—8
—1
ss 5.7 x 10
mole»liter

I
(hp -

2.9 x 1 0 ~ 1 0 mole.liter"1

These values were substituted in equations (12) and w was calculated as a
function of t and of (h ) . The results of these calculations have been
—
o
plotted in Figure 25, where they may be compared with the experimental
data. The closeness of fit suggests that the errors made in the various
assumptions must have been compensating. This is certainly true of the
error made in assuming that the outside hormone concentration, (h ) , remains
constant, and of that made in assuming that the concentration of inhibitor
in the cell, (i), is not decreased by further enzymatic degradation or by
diffusion out of the cell.

The first error would tend to increase the
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theoretical value of w and the second to decrease it.

We know of course

that the inhibitor does diffuse into the serosal bath.

Hence in reality

both the hormone concentration outside and the inhibitor concentration
inside are less for t > 0 than is predicted by the model.
The theoretical response (i.e., the loss in mg during the first 60
min of activity) can be calculated at each hormone concentration by numerical integration of the expression

L

L has been calculated for values of (h ) from 2.5 to 160 muM. The theo—
o
retical curve has been plotted in Figure 26 together with the experimental
data. There is excellent agreement between theory and experiment except
for values of (h ) exceeding 40 muM. It is clear from Figure 26 that the
o
experimentally determined response saturates more rapidly than the theory
would indicate. We can account for at least part of this discrepancy in
an approximation involved in one of the assumptions of the theoretical
model.

We assumed in equation (6) that the total water permeability, call

it w , was proportional to the concentration of hormone-receptor complex.
However, we previously presented evidence that the hormone acted on a permeability barrier near the mucosal membrane of the epithelial cells
(Introduction).
and let w

Let w

be the permeability that is affected by the hormone,

be the permeability of the tissue between the hormone-affected

s
permeability barrier and the serosal side of the bladder. Then since the
reciprocals of permeabilities in series are additive (like resistances),
we have

1
T

1
M

W

W

or
W

T

=

1
+

Vs
W

M + WS

Therefore, the actually measured permeability, w , is proportional to the
hormone regulated permeability, w , only when w

is small compared to w .

Clearly if w^ is approaching an asymptotic limit, w
asymptotic limit.

will approach a lower
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In summary, we have analyzed our measurements of the time course of
the action of oxytocin in terms of a theoretical model.
obtained.

Six constants were

Two of these, L and (h'), are probably characteristic of the

bladder itself and of the experimental design.

The remaining four con-

stants, a, b, K , and K , should be characteristic of the hormone,

a re-

lates to the permeability of the hormone,

b is the first order rate con-

stant of the inactivation of the hormone.

K^ is the dissociation constant

of the hormone-receptor complex, and K_ is the dissociation constant of the
I
inactivated-hormone-receptor complex. A similar analysis must now be applied to the time course of action of other neurohypophyseal hormones to
determine whether these constants are really characteristic of the hormone,
and whether by this means we can gain insight into the structure-function
relationships of these hormones.
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DISCUSSION

In our first experimental results we found that the particle-free
supernatant fraction of a homogenate of the toad bladder contained hormone
inactivating activity (Figure 13).

It was found that when hormone, in this

case AVP, was incubated with the supernatant fraction, the hormone activity
decreased exponentially with time (Figure 14).

This evidence supported the

view that the inactivation of hormone was enzymatic, and not due to an inhibitor of hormone action already present in the bladder fraction, or to
-'binding of the hormone.

The sensitivity of the hormone inactivating activity

to cold storage and to heat (Figures 15 and 16) also supported the view that
an enzyme was responsible for the inactivation of hormone.

Non-specific

binding did not seem to be involved; for instance the activity of hormone
was not decreased by incubation with bovine serum albumin, even in the
presence of cysteine.

More directly, we found that when oxytocin was in-

cubated with our best inactivating preparation, and the incubation mixture
examined chromatographically, the amount of ninhydrin positive material increased and the amount of oxytocin decreased (Figure 21). Furthermore, when
the incubation mixture was treated with performic acid and then chromatographed, a dense spot appeared in the position of cysteic acid (Figure 22).
Thus it appeared that oxytocin was being enzymatically degraded, and that at
least one of the bonds being split could be identified as the N-terminal
half-cystinyl-tyrosine bond.
The results obtained using L-cystine-di-p-naphthylamide (CDNA) as a
substrate tend to corroborate the conclusions drawn from the hormone inactivation studies.
peptide bond.

CDNA contains, like oxytocin, an N-terminal cystinylIt was found that the ammonium sulfate fraction of the super-

natant, precipitating between 50 and 70% saturation (S(50-70)) contained
the greatest amount of hormone inactivating activity (Figure 19). This
fraction also contained the greatest amount of CDNAase activity (Table V ) .
Moreover the specific activities towards the two substrates were comparable.
The rate of inactivation of oxytocin by S(50-70) in the presence of 1 mM
cysteine was on the average 35 muM per mg protein per hr (Results, A ) . The
average rate of splitting of CDNA by S(50-70) in the presence of 1 mM
cysteine was 70 muM per mg protein per hr (Table VII). Clearly the CDNAase
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activity was great enough to account for the hormone inactivating activity.
Not only were the fractionation patterns of the two activities similar, but
these two activities were similarly activated by cysteine and inactivated
by N-ethylmaleimide.

Stimulation of hormone inactivation by cysteine is

shown in Figure 15, and inhibition of the inactivation by NEM in Figure 17.
1 mM cysteine almost doubled the CDNAase activity (Table VII), and 1 mM NEM
inhibited this activity 40% (Table VIII).

Neither the inactivation of hor-

mone nor the splitting of CDNA, however, had an absolute requirement for
cysteine.

In both cases there was considerable activity in the absence of

cysteine.

Another similarity between the two activities is that both were

partially inactivated after a few minutes at 50

C (Figure 16 and Table X ) .

These similarities between the hormone inactivation activity and the
CDNAase activity, together with the direct evidence that the- N-terminal
half-cystinyl-tyrosine bond of oxytocin was split, support the view that an
oxytocin inactivating enzyme is present, and that this enzyme splits Nterminal half-cystinyl-peptide bonds, such as are present in all of the
neurohypophyseal hormones and in the synthetic substrate CDNA.

As a matter

of fact, the natural hormones, arginine vasopressin, arginine vasotocin,
lysine vasopressin, and oxytocin, as well as the synthetic analog, oxytocin
ring amide (see Table III for structures), were all shown to be inactivated
by the supernatant fraction, S (Figure 18).
occurs in all of these hormones.

The half-cystinyl-tyrosine bond

A final piece of evidence favorable to

the above hypothesis is that oxytocin was an inhibitor of CDNAase activity
(Table XI).

It would be interesting to test whether CDNA, on the other

hand, is an inhibitor of oxytocin inactivation.

This we have not yet done.

We have discussed the evidence supporting the hypothesis that a
single enzyme is attacking both CDNA and oxytocin.
the specificity of this enzyme.

We will now inquire into

We have already mentioned that the super-

natant fraction, S, inactivated all the natural neurohypophyseal hormones
and one synthetic hormone.

The natural hormones differ from one another in

only one or two residues out of nine, and oxytocin ring amide differs from
oxytocin in that three residues are removed from the C-terminal end of the
molecule.

These different molecules contain many similar bonds, among which

is, of course, the half-cystinyl-tyrosine bond.

Therefore even if the same

enzyme were responsible for the inactivation of all of these species, a lack
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of specificity would not necessarily be indicated.

On the other hand, we

have tested our best preparations with the synthetic substrates L-leucine/3-naphthylamide (LNA) and D,L-alanine-^-naphthylamide (ANA).

We found

that compared to the specific CDNAase activity, there was 8 times as much
LNAase activity and about 1.5 times as much ANAase activity.

Moreover, by

a number of criteria, the CDNAase and LNAase activities belonged to the same
enzyme.

For instance, both activities precipitated in the same ammonium

sulfate fraction (Table IX); they showed similar dependence on pH (Figure
24); and the ratio of the two activities remained constant during progressive inactivation by heat (Table X ) .

But there were also some results

differentiating between these two activities.

For instance, cysteine (1 mM)

was found to increase the CDNAase activity of S(50-70)D
no effect on the LNAase activity (Table XI).

60% while it had

This might be explained if

cysteine acted primarily on the substrate, CDNA, forming a less bulky and
possibly more easily attacked mixed disulfide.

Also, oxytocin inhibited

LNAase more than CDNAase, 60% as compared to 30% (Table XI).

Again this

could be explained if the enzyme binds cystine peptides better than leucine
peptides and hence oxytocin competes more effectively with LNA than with
CDNA.

There are other minor differences in Table XI between the effect of

various agents on these two activities.
explanation.

For these there is no apparent

All in all, it might be that at least a large part of the

CDNAase activity and of the LNAase activity resides in a single enzyme.
Thus it appears that the hormone inactivating, CDNA splitting enzyme is not
absolutely specific for N-terminal cystinyl-peptide bonds.

It seems to

split also N-terminal leucinyl-peptide bonds.
At the end of the Introduction we mentioned pregnancy serum oxytocinase.
enzyme.

Let us see how that enzyme compares with our hormone inactivating

As we said, pregnancy serum oxytocinase is found in the plasma of

pregnant women in increasing amounts until birth.
is thought to be the placenta.

The origin of this enzyme

Here, as with the toad bladder, the inacti-

vating enzyme is associated with the target organ of the hormone, in this
case, the uterus.

Pregnancy serum oxytocinase has also been shown to split

the cystinyl-tyrosine bond of oxytocin.
berger et al. , 1960).

It also splits vasopressin (Winters-

The best preparations of pregnancy serum oxytocinase

split CDNA at the rate of 2l5 x 10~ moles of ft -naphthylamine liberated
per mg protein per hour.

This was 4500 times the specific activity of the
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starting material (Tuppy and Wintersberger, 1960).

Our best preparations,

which had been purified 3 or 4 times, had a specific CDNAase activity of
about 1/200 of that of purified pregnancy serum oxytocinase (Figure 23).
Clearly our starting material had a higher specific CDNAase activity to
begin with.

The best preparation of pregnancy serum oxytocinase split LNA

11 times faster than CDNA, and with less pure preparations the ratio of
activities was even greater.

In fact the decrease in this ratio was used

by Tuppy and Wintersberger as an indication of purification.

Our best pre-

parations split LNA 8 times as fast as CDNA.
We see then that there are basic similarities between the hormone inactivating enzyme from the toad bladder and pregnancy serum oxytocinase.
There are however some important differences as well.

The rate of hydrolysis

of CDNA by pregnancy serum oxytocinase was decreased 30% by 1 mM cysteine
and was unaffected by 1 mM NEM pr by 1 mM iodoacetic a d d (Tuppy and Nesvadba, 1957> ; Tuppy and Wintersberger, 1960).

Clearly these results differ

from ours in which the latter two agents were inhibitory (Table VIII), and
cysteine increased CDNAase activity 80% (Table VII).
Let us compare our hormone inactivating enzyme now with the ubiquitous leucine aminopeptidase.

L-leucineamide and L-leucine-yf/-naphthyl-

amide are substrates for this enzyme, which appears to be relatively nonspecific except in its requirement for free -^-amino group.

The enzyme

purified from swine kidney is unaffected by glutathione, iodoacetamide, or
parahydroxymercuribenzoate (Smith and Speckman, 1955).

It is activated by

either Mn

or Mg

and is inhibited by versene and pyrophosphate (cf.

Table XI).

Activity rises from pH 6.0 to pH 7.8 and then remains constant

up to pH 9.3 (cf. Figure 24). Finally, it was found that leucine aminopeptidase hydrolysed oxytocin very slowly (Hall and Smith, 1957).

N-terminal

half-cystinyl-peptide bonds appear to be resistant to the action of this
enzyme.

In all these characteristics then leucine aminopeptidase differs

from the hormone inactivating enzyme of the toad bladder.
As mentioned in the Introduction, AVP has been shown to be inactivated by incubation with rat kidney slices, and this inactivation is inhibited by oxytocin and by parahydroxymercuribenzoate (Smith and Sachs,
1961).

Other preparations inactivating the neurohypophyseal hormones have

been cited in the Introduction, but none of these, as far as I know, are
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well characterized.

We may conclude that the hormone inactivating enzyme

from the toad bladder is different from pregnancy serum oxytocinase.

It

differs also from leucine aminopeptidase and from all other well characterized aminopeptidases.
We have found then that extracts of the toad bladder inactivate oxytocin and its analogs.

We have presented evidence that this inactivation

is due to an enzyme which we have begun to characterize, and which, on the
basis of this characterization, appears to be unique.

Next, we wanted to

show that the intact bladder was capable of inactivating oxytocin; that is,
that the inactivating enzyme isolated from the homogenized bladder functions
as such in the intact bladder.

This hypothesis was consistent with our

first observations on the kinetics of hormone action (Figure 25); that is,
with the observed decline in the effect of oxytocin on the water permeability of the bladder.

However we could not exclude, just on the basis of

these observations, other reasonable hypotheses.

Neither irreversible

changes in the isolated bladder (Table XII, exp. a ) , nor decreases in the
osmotic gradient across the bladder (exp. b ) , nor depletion of exogenous
substrate (exp. c ) , nor changes in pH were responsible for the observed
decline in effect.

In fact, it was found that the cause of the decline

resided not in a change in the state of the bladder itself, which was capable of responding fully again, but in a change in the state of the serosal
bath (exp. d ) . This then appeared to verify the hypothesis that the decline
in effect of hormone was due simply to inactivation of the hormone.

How-

ever, when the amount of hormone estimated to be inactivated was added as
an additional dose, the second response was still lower than expected
(exp. e ) ; this was true even when the second dose was equal to the first
(exp. f and g).

We were thus led to the conclusion that there must be some-

thing accumulating in the Ringer's of the serosal bath inhibiting the action
of oxytocin on the bladder.

We then actually found that an inhibitory sub-

stance was washed from the bladders into the serosal bath during the control
period, before any oxytocin had been added; and we showed that this inhibitory substance was not enzymatic (exp. h and i).

Moreover, the amount of

inhibitor that was washed from a bladder could account fully for the observed decline in effect of a dose of hormone.

Hence it appeared that there

was not significant enzymatic inactivation of oxytocin by the intact bladder.
However, we continued to study this inhibitor and found that the amount
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that came off in a second washing was considerably less than in the first
(exp. j ) . in all experiments, however, the bladders were washed for at
least 40 minutes and often longer in different Ringer's than that in which
they received at least one dose of oxytocin.

In all of these cases, the ef-

fect of the dose declined just as in Figure 25, or Figure 27. Therefore,
since we were led to explain the decline in effect as a result of inhibition,
and since we actually found an inhibitor in freshly excised bladders, and
since this inhibitor was found to be depleted by washing, we were led to
the view that new inhibitor must be formed in the presence of hormone.
We now asked how a hormone inhibitor could be formed in response to
the hormone itself.

One way is that the inhibitor be formed by an enzymatic

change in the hormone molecule, such that the changed molecule still combines with the receptor site of the hormone but is nonetheless inactive.
We know that some close structural analogs of oxytocin are effective inhibitors of hormone action (Table IV) . Here then is a role for a hormone
inactivating enzyme, the properties of which could be similar to those
described for the hormone inactivating activity of the toad bladder supernatant fraction,

This enzyme could inactivate endogenous or exogenous

hormone, and the product of the inactivation could compete with the hormone
for its receptor sites; i.e., the product of the inactivation would be a
competitive inhibitor of the hormone.

We would then explain that the in-

hibitor washed from freshly excised bladders was due to the accumulation
in the bladder of the product of the enzymatic inactivation of endogenous
hormone.

This hypothesis should be subject to direct verification by the

isolation of the inhibitor, both from the serosal bath of the intact bladder
and from the incubation mixture of hormone and inactivating enzyme.
We next constructed a model of hormone-bladder interaction based
partly on the above hypothesis, which combined the observations on the inactivating enzyme with those on the inhibitor released into the serosal
bath.

The assumptions of that model have already been thoroughly discussed

(Experimental, Section E).

In translating the model into mathematical

equations certain approximations were made, the validity of which we had
some reason to doubt.

These were, in particular, that the outside hormone

concentration, (hQ) remains constant in time (i.e., that the decline in
effect is due solely to the accumulation of inhibitor), and that the inhibitor, I, is formed at a rate which is large compared to the rate of its
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depletion by diffusion and by enzymatic degradation (i.e., that the rate of
increase of (i) is simply the rate of inactivation of hormone).

It was

found however that substantial amounts of inhibitor did appear in the serosal bath.

Hence the inhibitor was diffusing out of the cells.

Therefore,

the actual rate of formation of inhibitor, and hence the rate of inactivation of hormone, must be greater than the theoretical rate
the concentration of inhibitor in the cells remain high.

in order that

In that case, we

could no longer ignore the depletion of hormone in the serosal bath.

Never-

theless we made these approximations in order to be able to solve the theoretical equations in closed form.

The fairly close fit of the theoretical

solution to the experimental values (Figures 25 and 26) provides at least
some justification for these approximations, that is, assuming that the
major assumptions of the model are correct.
Whether or not the assumptions of the model are correct, we have
derived an expression which can be made to fit the experimental data with
fair accuracy.

The six constants of the theoretical expression are evaluated

from the data,

Four of these, as was pointed out before, are probably

characteristic of the hormone.

We can expect then that if the different

hormone analogs show different kinetics of action, as there is indication
that they do (Figure 11), analysis of the data obtained with each analog
should provide at least four constants characteristic of that analog.

Pre-

sently, analogs are compared on the basis of one characteristic constant
related to the magnitude of response per mg of hormone (cf. Table III).
This comparison has not been particularly fruitful in elucidating structurefunction relationships (Boissonnas et al., 1961).

Possibly comparison on

the baais of four characteristic constants per analog might be more helpful,
especially if these constants are not merely empirical but can be related
to some model of hormone action.

These ideas must be tested by applying

the same analysis to a number of analogs of oxytocin.
It might be pointed out that the response of the toad bladder to
neurohypophyseal hormones as measured by changes in the short-circuit current
looks very similar to the response measured by changes in the water permeability.

This can be seen by comparing Figure 10 and Figure 25.

potential difference varies in a similar way.

The

For obvious reasons, it would

be more convenient to base our analysis on electrical rather than gravimetric measurements.

It must be determined whether the variation, both with
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time and with hormone concentration, of the electrical properties of the
bladder parallels the variation with these parameters of the water permeability.
We have worked with the isolated toad bladder, a target organ for the
neurohypophyseal hormones.

Our proposed model for the control of the action

of these hormones has been based on observations of this isolated system.
We must now ask whether these observations are relevant to the actual time
course of hormone action in the animal.

The rise and decline of the effect

of oxytocin on the isolated bladder occurs in a time interval of a couple
of hours.

We mentioned in the Introduction that according to some inves-

tigators, doses of neurohypophyseal hormones injected into mammals seem to
disappear from the circulation with a half-life of a few minutes.

On the

other hand, in Figure 4 we see that the actual response of the dog to an
injection of vasopressin or oxytocin measured as a decrease in urine flow
did not decline appreciably after one hour.

Similarly, in the toad, the

effect of an injected dose of hormone on free water clearance lasted for a
matter of hours (Figure 2).

Thus the time course of the effect of a dose

of hormone injected into the animal is roughly the same as the time course
of the effect of a dose of hormone on the isolated bladder.

In any case,

what we are actually dealing with in the whole animal is a dynamic state
in which hormone activity is dependent on the rates of formation and degradation of hormone, and, we suggest, the rates of formation and degradation of hormone inhibitor.

From our analysis we suggest further that the

effect of the inhibitor would be to limit the duration of the response of
target cells; that is„ a cell would respond acutely to an increase in hormone concentration, and would then become refractory due to an increase in
inhibitor concentration.
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